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The prevalence of deoxynivalenol (DON) concerns swine producers in Western Canada. There 
has been extensive research into the effects of DON in pigs, much of which targets young animals 
and/or in short-term studies. The objectives of this thesis were to determine the effects of long-
term exposure to DON-contaminated diets on growth performance, carcass characteristics, and 
health in finisher (Exp. 1) and grower-finisher (Exp. 2) pigs. In experiment 1, 200 pigs were housed 
in groups of 5 pigs/pen (n=10 pens/treatment) for a 6-wk feeding trial. In experiment 2, 240 pigs 
housed in groups of 6 pigs/pen (n=10 pens/treatment) were used in an 11-wk feeding trial. Pigs 
were fed a control diet without DON (CONT) or the basal diet with 1, 3, or 5 ppm DON (DON1, 
DON3, and DON5, respectively). Weekly pig BW and pen-wise feed intake was recorded to 
determine average daily gain (ADG), average daily feed intake (ADFI), and feed efficiency (G:F). 
Blood samples were collected on d 0, 14, and 42 for Exp. 1 and d 0, 14, and 42 and on d 42, 56, 
and 84 for Exp. 2. Serum was analyzed for liver and kidney health and immune response to a 
vaccine challenge. Carcass data was collected at the end of Exp. 2. In both studies, nitrogen (N)-
balance was conducted to determine the effect of DON on N-utilization. In Exp. 1, pigs fed DON3 
and DON5 had consistently reduced (P < 0.05) ADFI and ADG from d 0-28 compared to CONT 
and DON1, after which there was no effect (P > 0.05) on ADFI, ADG, and G:F. N-retention was 
reduced (P < 0.05) in DON3 and DON5 pigs. In Exp. 2, DON3 and DON5 diets reduced ADG (P 
< 0.05) during the grower phase and the overall experimental period compared to CONT-fed pigs. 
There was no treatment effect on ADG in the finisher phase (P > 0.05) but ADFI during the first 
week was lower (P < 0.05) in DON3 and DON5-fed pigs compared to CONT and DON1. 
Compared to CONT, ADFI in the finisher phase and overall was lower (P < 0.05) in DON-fed 
pigs compared to CONT. For both phases, there was no DON effect (P > 0.05) on G:F. Finisher 
N-balance results showed no impact of DON intake on N-retention (P > 0.05), however, N-
retention was reduced in the grower pigs fed DON3 and DON5 diets (P < 0.05) compared to 
CONT. There were no treatment effects (P > 0.05) on carcass traits, health, or immune response. 
The lack of effect on G:F suggests negative effects of DON on growth performance are largely 
due to impaired feed intake. Overall, the performance was less affected in the grower-finisher 
study relative to the finisher study. Further, regardless of age, there was evidence that pigs can 
adapt to DON over the long-term. This information will allow producers to adjust feeding 
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Mycotoxins are a major contributor to grain contamination and have been reported to be 
increasing yearly (BIOMIN, 2019). For example, in a 2019 Biomin report, about 79% of wheat 
sampled in North America was contaminated with deoxynivalenol (DON), a Fusarium mycotoxin 
(Bushnell et al., 2003). It is estimated that in North America, about 5 billion dollars in agricultural 
revenue is lost due to mycotoxin contamination of cereal grains (Wouter et al., 2019). There is 
evidence suggesting that DON and other harmful mycotoxins increase in incidence annually 
(Bianchini et al., 2015), rendering large quantities of cereal grains unavailable for human food 
production, instead of being downgraded for use in livestock feed. Thus, there is a need to find 
practical ways of using these contaminated grains in animal production systems as a feed resource. 
The Canadian Feed Inspection Agency (CFIA) has suggested feeding limits for many mycotoxins 
for different livestock species. For example, in pigs, a maximum of 1 ppm DON is allowable in 
complete diets, irrespective of the age of the pig. Feeding DON-contaminated diets to pigs above 
the CFIA recommendations has been reported to have negative effects on growth performance and 
health of pigs (Trenholm et al., 1994;  Girardet et al., 2011; Van Le Thanh et al., 2015). For 
example, when diets contaminated with DON above allowable limits were fed to weanling pigs, 
Weaver et al. (2013) reported and Van Le Thanh et al. (2015) reported reduced growth 
performance. However, the effects of DON intake have been inconsistent, with other studies 
reporting no effect of feeding DON-contaminated diets on pig health and growth performance 
(Øvernes et al., 1997; House et al., 2002). Indeed, differences in health and growth performance 
response of pigs fed DON-contaminated diets are thought to be related to the physiological age, 
the concentration of DON in the diets, and the duration of exposure (House et al., 2002; Øvernes 
et al., 1997). For example, it is suggested that younger pigs may respond more negatively relative 
to finishing pigs to DON, but the duration of exposure may also influence the response (Øvernes 
et al., 1997; House et al., 2002; Weaver et al., 2013; Van Le Thanh et al.,2015). Given the 
increasing incidence of DON contamination of grains over the last few years, there is the need and 
our responsibility to evaluate strategies to utilize DON-contaminated grains in feeding pigs, 
including examining the potential for adaptation and recovery from the DON-induced impact on 
health, and growth performance for agricultural sustainability. Therefore, the focus of this thesis 
was to determine the impact of long term feeding of DON-contaminated diets in growing-finishing 
pigs on health, nutrient utilization, growth performance, and carcass characteristics.  
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2.0 LITERATURE REVIEW 
2.1 Introduction 
Mycotoxins are secondary metabolites produced by molds and fungi which, when ingested, 
exert toxic effects resulting in adverse physiological responses in animals and humans (Peraica et 
al., 1999; Bonnet et al., 2012; Marroquín-Cardona et al., 2014). This contamination is the result of 
cereal grains that are infested with molds or fungi, which produce mycotoxins while in the field or 
under storage (Schuh 2013; Schatzmayr and Streit, 2013). About 400 mycotoxins have been 
identified, however, of principal importance to animal agriculture are aflatoxins (AF), T-2 toxin 
(T-2), HT-2 toxin (HT-2), DON, nivalenol (NIV), fumonisin (FUM), zearalenone (ZEA), 
ochratoxin A (OTA), and ergot alkaloids because they are commonly found in cereal grains (e.g. 
wheat, barley, and corn) used for livestock feed (Wu, 2004; Schuh, 2013). The incidence of 
mycotoxins is on the rise in recent years mainly due to the fungal adaptation to environmental 
changes attributed to global climatic variations (Canadian Grain Commission, 2019; FAO, 2018) 
as well as increased international trade and transport of agricultural goods (FAO, 2018). There is 
evidence suggesting that increasing global temperature and erratic weather conditions have 
increased the proliferation of new fungal species in locations where mycotoxin prevalence was 
historically low (Binder et al., 2007). For example, in North America, during the 2019 crop year, 
the incidence of DON contamination in grain samples had risen to 79 % from 65 % in 2018. Even 
more remarkable was the increase in ZEA contamination from 26 % in 2018 to 56 % in 2019 
(Biomin, 2018; 2019). The Government of Saskatchewan, in its Economic Review, reported that 
approximately 12.90 and 14.41 million tonnes of wheat was harvested in the 2017 and 2018 
cropping seasons, respectively (Saskatchewan, 2017; 2018). Contamination by Fusarium alone 
was reported to have caused about 2.1 million tonnes of wheat to be downgraded in 2018, 
representing 14.2% of the total wheat production (Canada Grains Council, 2020). With the 
reported effects of mycotoxins on animal health and growth performance, avoiding these 
contaminated grains would be the ideal approach, however, downgraded grains due to mycotoxin 
contamination are used in livestock feed, making the feeding of these grains difficult to avoid 
(Bianchini et al., 2015; Tittlemier et al., 2013b).  
Since it is not entirely possible to avoid mycotoxin contamination of grains, the CFIA has 
set regulatory guidance limits for different mycotoxins in complete diets for livestock species. For 
example, cattle and poultry can be fed diets containing up to 5 ppm DON, while a maximum of 1 
3 
  
ppm is allowed in swine diets. However, with sustainable animal production in mind, it is to an 
extent our responsibility to determine methods to utilize feedstuffs that are not suitable for human 
consumption, including DON-contaminated grains. This review will highlight some reported 
effects of mycotoxin contamination (mainly DON) in swine diets and the effects on health, nutrient 
utilization, and growth performance. Further, this review will elucidate some possible mitigating 
strategies that allow for the utilization of DON-contaminated grains in swine diets. 
 
2.2 Economic importance of mycotoxins in animal agriculture  
The economic impact of mycotoxins and specifically DON, in animal production is yet to 
be fully explored and understood (Marroquín-Cardona et al., 2014). Recent articles in ‘All About 
Feed’ in 2016 discussed the issues of mycotoxins, stating that with advances in mycotoxin analysis 
it has become clear that the mycotoxin problem is much larger than once imagined and the costs 
associated with mycotoxin contamination will worsen with climate change, as has been supported 
by data from the FAO (2018). It has been reported that about 25% of all food produced globally is 
exposed to mycotoxin contamination. Further, global losses of food due to the prevalence of 
mycotoxins is about 1 billion tonnes annually (Iheshiulor et al., 2011). The exact extent of this 
problem is difficult to determine because analysis of mycotoxin levels in feed is highly variable 
and dependent on sampling techniques and the analytical methods used (Whitaker et al., 2000; 
Hallier et al., 2011). Total economic losses attributed to mycotoxins, as identified by Wu (2007), 
are made up of market rejection losses and animal production losses. Some of the costs associated 
with mycotoxins include laboratory analysis, quality management and regulations, research and 
development, agricultural extension, and legal issues, as well as reduced animal performance and 
health and downgrading of grains for human consumption to use in livestock feed (Charmley et 
al., 1995; Marroquín-Cardona et al., 2014). Others include medical costs, management strategies 
to reduce exposure to mycotoxins, and import restrictions on animal feed ingredients (Marroquín-
Cardona et al., 2014). Another major cost that can be attributed to mycotoxins is the recall of 
animal products, such as milk and eggs from the dairy and poultry industries, respectively 
(Sobrova et al., 2010; Winstanley, 2013). 
 With Canada as the 3rd largest global exporter of wheat behind the USA and Russia 
according to FAO 2017 data and the 10th largest pork producer, with approximately 2.1 million 
tonnes, it is clear how important these industries are to Canada and Saskatchewan’s economy. The 
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constant annual increase in production of wheat, oats, barley, and other grains has, unfortunately, 
been supporting the proliferation and adaptation of Fusarium due to the relative increase humidity 
of recent seasons compared to former seasons, the availability of substrate for reproduction, and 
the movement of contaminated grain across the country. This, therefore, results in a long-term 
challenge to grain producers in Saskatchewan and Canada (Saskatchewan, 2018; Canada Grains 
Council, 2020). Further, the cost of mycotoxin management may keep increasing unless 
dependable, affordable, and practical methods of controlling mycotoxins are developed and made 
readily accessible. With a quarter of the world’s food crops affected by mycotoxins and thus, the 
real and apparent economic impacts call for the need to be able to adequately quantify these losses 
(CAST, 1989; Robens and Cardwell, 2003; Iheshiulor et al., 2011), for example, improving the 
variability and inconsistency of testing  (Whitaker et al., 2000; Marroquín-Cardona et al., 2014).  
 
2.3 Deoxynivalenol (DON) in animal agriculture 
Deoxynivalenol is significant to agriculture because it is s the most prevalent mycotoxin 
affecting cereal grains (Rotter et al., 1996; Chaytor et al., 2011). The World Mycotoxin Survey 
(BIOMIN, 2019) stated that DON occurrence in many grain samples tested in North America, such 
as corn, barley, wheat, and soybean, had risen from 67% in 2018 to 79% in 2019. While all farm 
animal species are affected to some extent by DON contamination (D’Mello et al., 1999; Placinta 
et al., 1999), physiological and genetic differences in species result in varied responses to DON 
exposure (Santurio, 2000; Bonnet et al., 2012). The common response parameter observed with 
DON contamination among different species is poor feed intake, which leads to impaired growth 
and poor health (Gajęcki, 2010). The pig is particularly susceptible to DON contamination, with 
cattle and poultry showing reduced susceptibility and severity of response (Savard et al., 2015).  
The in vivo toxicokinetics of DON has been studied and reported on extensively in the 
literature (Rotter et al., 1996; Seeling et al., 2006; Pestka, 2007; Nagl et al., 2012; Schwartz-
Zimmermann et al., 2017), and even though the efficacy of intestinal uptake and metabolism of 
DON varies across farm animal species, all species possess some level or capacity to detoxify 
DON in the body (Maresca, 2013). It is, however, the extent of the detoxification and excretion 
that makes DON more or less toxic in one animal species versus another. Also, having the capacity 
to detoxify DON to its less toxic forms, for example, DOM-1, in the upper gastrointestinal tract 
before the small intestine also influences the susceptibility of a species to DON (Rotter et al., 1996; 
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Pestka, 2007; Maresca 2013). Anaerobic bacterial de-epoxidation and the conjugation of DON to 
glucuronic acid in vivo are reported to be the two important metabolic pathways of DON 
detoxification (Nagl et al., 2012). In mammals such as the pig, glucuronidation is the key metabolic 
pathway of detoxifying DON. This process enhances the polarity of the toxin increasing the 
excretion in urine and feces (Nagl et al., 2012). 
In ruminants, while the classic responses of feed refusal and impaired feeding behavior are 
observed when feeding diets containing DON (D’Mello et al., 1999), there is evidence of 
biotransformation of DON in the rumen due to the large microbial population (Upadhaya et al., 
2010), which is likely one of the reasons for the reduced impact of DON. In calves and lactating 
cows, susceptibility is higher compared to older cattle (Seeling et al., 2006). It has been reported 
that when DON-contaminated diets are fed to lactating cows an acute immune response can result 
(Marczuk et al., 2012). Even though ruminants are known to have the ability to bio-transform 
DON, lactating cows also have been reported to directly pass on DON and other mycotoxins, such 
as AF, to newborn calves and humans through milk and milk products (Sobrova et al., 2010; 
Astley, 2013; Winstanley, 2013). Various studies have shown varied results of DON on ruminants. 
For example, while some studies suggest no impact of DON on lactating cows fed DON up to 104 
mg cow/day (Trenholm et al., 1984; Charmley et al., 1993; Ingalls, 1996) others reported reduced 
feed intake (Trenholm et al., 1984), reduced rumen microbial protein, and increased rumen 
ammonia nitrogen (Dänicke et al., 2005). Although reports have shown varied effects of DON on 
ruminants, largely at relatively lower levels, DON tends to be easily controlled and broken down 
by rumen enzymes, micro-flora, and fauna such as bacteria, fungi, and protozoa, and so, in general, 
there is little to no negative effect on ruminants. For example, the enzyme de-epoxidase has been 
reported to detoxify DON (Upadhaya et al., 2010; Gallo et al., 2015). Rumen fluid has been shown 
to change pure DON into less toxic forms, de-epoxy-deoxynivalenol (DOM-1) (Kollarczik et al., 
1994) but no DON degrading strain could be cultured (Schuh, 2013) until the BBSH 797 strain of 
bacteria was isolated in 2006 and has now become the active ingredient in some commercial 
products used in Europe (Fuchs et al., 2002; Plank et al., 2009; Awad et al., 2010; Sayyari et al., 
2018). However, at significantly higher concentrations, and in the presence of other mycotoxins, 
DON can cause rumen dysfunction. When the rumen function is impaired, DON reaches other 
parts of the ruminant gut, leading to responses such as immunosuppression, low feed intake, and 
impaired growth (Gajęcki, 2010). The economic impact of DON on cattle is reported to be higher 
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in dairy cattle due to their incredibly high-performance levels compared to beef cattle (Seeling et 
al., 2006). 
In poultry, it is reported that response to DON is often observed at higher levels than that 
known for swine (e.g. 5 ppm; Trenholm et al., 1984) and that this level of intake has been 
associated with the increased rate of passage of digested feed from the intake to excretion, leading 
to significantly less time for DON to remain in the gut, reducing bioavailability (Prelusky et al., 
1986). In poultry, DON reduces feed intake (Swamy et al., 2014), increases oxidative stress 
(Ghareeb et al., 2015), and impairs nutrient uptake (Awad et al., 2010). In turkeys, 
immunosuppressive effects of DON ingestion lead to increased susceptibility to disease 
(Chowdhury et al., 2005a; 2005b). As with ruminants, chickens have a mechanism of microbial 
detoxification of DON in the gut to the less toxic DOM-1. It has also been reported that poultry 
products such as eggs contain traces of DON (Bhat et al., 2010), which may lead to further losses 
due to product recalls. 
Animal models, such as rodents, have been used to study and understand DON and its 
impact on animal systems. Arnold et al. (1986) used mice and rats to understand the mechanisms 
by which DON affects animals and concluded that DON acts as a gastro-intestinal irritant and 
impairs the function of the immune system (Pestka et al., 1987). In mice, DON ingestion reduced 
growth performance, and this was attributed to reduced feed intake. It was further explained that 
the lack of appetite was due to the regulation and deregulation of satiety hormones, such as peptide 
YY (PYY) and cholecystokinin (CCK), by DON and DON metabolites in circulation (Challis et 
al., 2003; Flannery et al., 2012). 
 
2.4 Effect of deoxynivalenol (DON) on swine production 
2.4.1 Effects of feeding DON-contaminated diets on growth performance and feed efficiency 
Previous research indicates that DON adversely affects the overall growth performance of 
pigs regardless of the length of exposure. For example, Kong et al. (2015) fed 14.6 mg DON per 
kg of feed to growing pigs and saw about a 70% drop in the average daily gain (ADG) when 
compared to pigs fed uncontaminated diets. Similarly, Serviento et al. (2018) reported that when 
pigs were fed DON-contaminated diets intermittently over a 28-d period, the overall ADG was 
lower in the DON-fed pigs compared to pigs fed DON-free diets. Reduction in growth performance 
of DON-fed pigs is suggested to be because of the effect of DON effect on feed intake. Impaired 
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feed intake is the main response of pigs to DON ingestion, and as dietary DON concentration 
increases, vomiting and complete feed refusal occur (Morrissey and Vesonder, 1985; Rotter et al., 
1996; Kong et al., 2015; Serviento et al., 2018). These effects lead to lower average daily feed 
intake (ADFI) and reduced growth and feed efficiency (Kong et al., 2015; Serviento et al., 2018). 
In pigs, age, previous exposure, and duration of exposure to DON have been shown to affect the 
overall impact of DON on feed intake (Serviento et al., 2018; Nguyen-Ba et al., 2020), which 
largely agrees with results from Flannery et al. (2011). 
In other studies, results have suggested little to no impact of DON ingestion on pig growth 
performance. For instance, House et al. (2002) observed no effect of 1 and 2 ppm dietary DON 
intake on ADG and feed efficiency but saw a significant reduction in ADFI. Likewise, Dänicke et 
al. (2004) reported no effect on growth performance (ADFI, ADG, and feed efficiency) in starter 
and grower pigs fed DON-contaminated diets (3.86 mg/kg feed) over a 35-d period. Others have 
reported interesting results such as a significant reduction in ADG by DON intake whereas ADFI 
and feed efficiency were unaffected (Li et al., 2018). Further, Reddy et al. (2018) saw no negative 
effect of DON on ADFI, but ADG and feed efficiency were significantly reduced, which led to an 
overall reduction in final BW. While the inconsistencies in the response to dietary DON ingestion 
in response parameters such as ADFI, ADG, and feed efficiency may be due to differences in 
dietary DON level, age of pig, and physiological state, this may also be evidence of variability in 
individual animal response (Kong et al., 2015; Serviento et al., 2018). The impact of DON on pigs 
may also be influenced by pig gender. It has been proposed that gilts are more susceptible and 
show greater negative responses compared to barrows  (House et al., 2002). Cote et al. (1985) 
conversely reported that males respond more severely to DON contamination. 
While the initial acute response to DON is well-characterized, there is evidence suggesting 
that when pigs are exposed to DON-contaminated diets for longer periods, there is the potential 
for reduced adverse response or adaptation over time. For example, Serviento et al. (2018) 
observed a 53% drop in ADG in pigs after initial exposure to DON. When DON was withdrawn 
and reintroduced, DON-fed pigs showed a 39% drop in ADG compared to control pigs. This 
suggests that subsequent exposure to DON will result in a reduced negative effect (Serviento et 
al., 2018) though, in this experiment, the pigs were older during the second exposure. It was also 
reported by Serviento et al. (2018) that after the immediate reduction in ADFI in pigs exposed to 
DON, intake and ADG recovered over 7 d to levels similar to those reported before DON exposure, 
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suggesting that pig performance can recover. In another study, Sayyari et al. (2018) fed pigs with 
diets up to 5.7 ppm DON and found no difference in ADFI and ADG after 5 weeks compared to 
pigs fed diets with no DON. Multiple or repeated exposures to DON at higher intake levels are 
thought to afford an improvement in the ability to tolerate lower doses (Flannery et al., 2011). 
Furthermore, an exposure of about 28 d has been recommended for a total recovery and adaptation 
to diets contaminated with DON, hence the reason why relatively shorter exposures to DON lead 
to more severe impacts (Serviento et al., 2018). 
  
2.4.2 Effects of feeding DON-contaminated diet on health and immune response  
Fusarium mycotoxins have potential immunomodulatory effects, with the immune system 
often considered the second most sensitive physiological system to DON toxicity after the gut 
(Maresca, 2013). For example, in the review by Maresca (2013), it was reported that DON and its 
derivatives can negatively impact immune cells such as B- and T-lymphocytes, natural killer cells, 
and macrophages in a dose-dependent manner. Increased blood cell counts (monocyte and 
hematocrit) in pigs fed DON-contaminated diets have been reported (Pinton et al., 2008; Chaytor 
et al., 2010). Other studies have reported an increase in serum antibodies, IgA and IgM, when pigs 
were fed DON-contaminated diets (Swamy et al., 2002; Goyarts et al., 2005; Tiemann et al., 2006). 
Pro-inflammatory cytokines such as TNFα, play a regulatory role in immune response function 
(Wu, 2018). There is evidence that when pigs are fed diets contamination with both DON and AF, 
there is an alteration in the concentration of TNFα. Attempts to characterize the negative effects 
of DON on the health of pigs have produced conflicting results, as some studies have reported that 
DON contamination of up to about 5 ppm does not affect blood chemistry parameters such as total 
proteins, enzyme activity, and phosphorus (Chaytor et al., 2011; Trenholm et al., 1994). Similarly, 
Rotter et al. (1995) reported only a temporary alteration in serum proteins in blood samples of 
DON-fed piglets and Accensi et al. (2006) reported that DON (840 µg/kg feed) fed to piglets did 
not affect immunoglobulin, lymphocyte, and cytokines concentration. 
 
2.4.3 Effects of DON-contaminated diets on organ and intestinal health and function in pigs 
The effect of DON contamination in pig diets has been reported to cause pathological 
changes and damage in different organs including the gut, liver, kidney, and spleen (Grenier et al., 
2013; Schuh, 2013). Further, organ damage such as liver fibrosis, bile duct hyperplasia, and 
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megakaryocytosis was reported in pigs fed diets contaminated with DON (Harvey et al., 1991; 
Chaytor et al., 2011; Grenier et al., 2013). There is evidence that suggests that feeding animals 
DON-contaminated diets has a negative effect on the overall health of the gut. Studies conducted 
both in vitro and in vivo have demonstrated that DON may inhibit the absorptive function and 
intestinal barrier permeability (Maresca et al., 2002; Grenier et al., 2013). In weanling pigs, 
reduced expression of tight junction proteins (e.g. occludin, claudin, etc.) was observed in the 
ileum of pigs fed DON-contaminated diets (Lessard et al., 2015). Indeed, evidence suggests that 
DON influences intestinal health and integrity, altering mucosal immune defense and antioxidant 
systems in the gut (Pinton et al., 2008; Accensi et al., 2006; Bracarense et al., 2012). The stability 
of the intestinal microbiome is an important parameter for intestinal health; therefore, the effect of 
DON contamination of intestinal health may be related to the effect of DON on the intestinal 
microbiome. Waché et al. (2009) studied the impact of feeding a DON-contaminated diet on the 
intestinal microbiome in pigs and concluded that DON led to an imbalance of the dynamics of the 
intestinal microbial communities. Overall, there is evidence on the impact of DON on intestinal 
health and function, as such mitigation strategies for DON, should focus on mitigating the impact 
on the gut. 
 
2.4.4 Effects of feeding DON-contaminated diet on carcass characteristics in pigs 
The impact of DON on carcass characteristics (carcass weight, backfat, and lean depth) has 
been reported in barrows and gilts and data suggests that DON has no negative effects (House et 
al., 2002). Likewise, Bergsjø et al. (1993) reported that while there was reduced carcass weight 
(65.3 kg vs 76.7 kg) and increased liver size (2.53% vs 2.25% of body weight) in pigs fed DON-
contaminated diets compared to DON-free diets, dressing percentage and lean yield were not 
different.  
 
2.4.5 Effects of feeding DON-contaminated diets on other physiological functions 
Some physiological functions have been reported to be affected by DON, largely these 
effects impact feeding behavior and feed intake (Flanery et al., 2012; Maresca 2013). For example, 
DON has been reported to affect neuroendocrine signaling, such as those related to serotonin, 
which can affect anorexigenic (e.g. insulin and leptin) or orexigenic (e.g. ghrelin) hormones, which 
can alter feed intake (Watterson et al., 2013; Pinton and Oswald, 2014). In mice, Flannery et al. 
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(2012) reported that DON exposure increased plasma levels of two key appetite-regulating 
hormones - peptide YY and cholecystokinin. Also, subcutaneously administered purified DON in 
male rats reportedly leads to poor feed intake and hormonal and metabolic dysfunction 
(Szkudelska et al., 2002). Additionally, hormones such as leptin and insulin, which are responsible 
for energy balance and the metabolism of carbohydrates, fats, and proteins, have been reported to 
be reduced in mice when fed 10 mg/kg DON (Kobayashi-Hattori et al., 2018). Even though the 
models used for these experiments were rodents, swine share similarities with these species in 
terms of metabolism.  
 
2.5 Determination of DON contamination 
A necessary step in mitigating the effects of DON in swine production is accurately 
determining DON content in feed ingredients and complete feeds. Unfortunately, there are large 
discrepancies and variability when it comes to the accuracy of testing for DON (Whitaker et al., 
2000; Beaulieu et al., 2009). For example, DON tested samples from the same source, sampled at 
the same time, but from different parts of a containing vessel can affect the overall accuracy of test 
results. For example, Whitaker et al. (2000) measured DON in 32 wheat samples from 24 lots and 
showed significant variations. Further, there is evidence that grain dust contains higher 
concentrations of DON than actual grains from the same sample (Sanders et al., 2013). For better 
consistency, less variability, and higher confidence in test results, Champeil et al. (2004) suggests 
the use of ground grain samples instead of whole-grain-based lab testing. Additionally, harvesting 
and storing procedures were shown to have an effect on DON levels in tested samples (Champeil 
et al., 2004). Hallier et al. (2011) added that during testing for DON, a longer duration of extraction 
showed significantly higher concentrations of DON compared to shorter duration, sample size had 
no effect on results but grinding or flour particulate size significantly affected the concentrations 
of DON recorded. With these challenges in mind, it is worth considering the biological analysis of 
samples such as blood and urine since extensive works by Goyarts and Dänicke, (2005), Nagl et 
al. (2012), and Schwartz-Zimmermann et al. (2014; 2017) have shown that there is a strong 
positive correlation between the intake of DON and its presence in the body of an animal. For 
example, when DON was introduced into mice, the level of DON in the bloodstream increased 
significantly and gradually reduced over time, within a few hours, there was practically no DON 
in the blood. This also supports the fact that, when DON is introduced into an animal, especially 
11 
  
monogastric species such as swine and poultry, it quickly undergoes breakdown by the liver into 
the less toxic glucuronide, while at the same time the kidneys actively expel the mycotoxin into 
the urine (Nagl et al., 2014), with the main route of excretion of absorbed DON in animals being 
via urine (Nagl et al., 2012). The specific effects of DON in any species are dependent on the level 
of DON present as well as the presence of other mycotoxins within the diet, with some mycotoxins 
having a synergistic effect when present together (Schuh, 2013). 
 
2.6 Mitigation strategies for DON in swine feed ingredients and complete diets 
While the best strategy to eliminate the negative effects of DON is to avoid feeding DON-
contaminated feed to swine, the increasing incidence of DON and other mycotoxins in feedstuffs 
(Placinta et al., 1999; Zhang et al., 2018) has made this increasingly difficult (House et al., 2002; 
Schatzmayr and Streit, 2013; FAO, 2017).  In recent times, the use of by-products from the food 
and biofuel industries, such as distiller’s dried grains with solubles (DDGS), wheat middling, 
wheat bran, corn (maize) meal, hulls,  and condensed distiller’s solubles (CDS), in swine nutrition 
has become popular (Zijlstra and Beltranena, 2013; Woyengo et al., 2014).  Unfortunately, these 
residual products end up containing concentrated levels of DON and other mycotoxins because the 
processing techniques are unable to deactivate or remove the toxin (Schaafsma et al., 2009). These 
challenges have also led to the use of techniques including blending contaminated ingredients with 
ingredients not contaminated with DON and other Fusarium mycotoxins which allows for 1) 
making efficient use of downgraded grains and highly DON concentrated co-products (Schaafsma 
et al., 2009); 2) maintaining profitable production by formulating diets to meet the regulatory 
requirements set by the CFIA (CFIA, 2017; Charmley et al., 1995); and 3) reducing the relative 
cost of feeding DON-contaminated diets as opposed to clean diets (Woyengo et al., 2014).  The 
increasing threat of DON has resulted in substantial research investigating effective measures for 
removal or decontamination of DON in swine feed ingredients and feeds and/or mitigating the 
negative effects of DON ingestion. Generally, DON mitigating strategies can be classified into 
physical, chemical, or biological modes of action (Charmley et al., 1995; Zhu et al., 2016; Luo et 




2.6.1 Physical methods of mitigating DON in feed ingredients and complete diets 
 Several physical methods of DON removal have been examined. For example, the use of 
physical abrasion to remove portions of the grain surface in a process known as pearling. In a study 
by Sovrani et al. (2012), DON content in grain was shown to be reduced by as much as 64% when 
the top 10% of the grain was pearled. This was generally in agreement with results from House et 
al. (2003), where 15 seconds of pearling resulted in the grains containing 34% of the initial DON 
analyzed (a 66% drop). The efficiency of pearling can be as high as 78% (Pinotti et al., 2016) but 
the process of pearling, though effective, also reduces the overall mass, crude protein, and fiber 
contents of the grains (House et al., 2003). Also, because pearling does not decontaminate DON, 
the mycotoxin may be redistributed in processing facilities through grain dust, which is known to 
contain significantly higher levels of DON compared to whole grains (Sanders et al., 2013).  
Another method is the use of near-infrared transmittance, applied by devices like the BoMill AB 
TriQ™ seed sorter, to sort Fusarium damaged kernels from bulk grain (Shahin and Symons, 2011; 
Kautzman et al., 2015). Other physical methods include quick-drying, the use of ultraviolet (UV) 
light, and the use of adsorption agents like clays (Zhu et al., 2016). Adsorbents are materials that 
have the binding potential to hold onto molecules on their surfaces (Shehata et al., 2000). The use 
of adsorbents, or binders as they are popularly known, relies on the fact that the physical structure 
of the binding agent gives it a charge coefficient that can form an attraction with a target molecule, 
in this case, DON (Kong et al., 2014). For example, some clays and dried yeast have shown some 
promise (Weaver et al., 2013).  
Zhu et al. (2016) further reported that while adsorbents are effective against AF, they are 
generally ineffective against DON and other mycotoxins such as OTA, T-2, HT-2, etc. These 
adsorbents can, however, be modified with quaternary long-chain alkyl/aryl amine (NR4
+) 
polymers which increases the hydrophobicity and adsorption potential, which may increase 
efficacy. On the contrary, some other studies have shown the efficacy of some other mycotoxin 
adsorbing agents in reducing the negative effects of DON on growing pigs (Awad et al., 2010).  
These inconsistent results have led to the modification of regular adsorbents with the other 
products yeast cell wall, lactic acid bacteria, and conidia of Aspergilli. Kong et al. (2014) reported 
in an in vitro study that yeast cell wall as a DON sequestering agent was the most potent among a 
group of adsorbents including 4 bentonite clays, cellulose A, Cellulose B, and activated charcoal. 
The yeast cell wall was able to bind about 22.9% of the DON in the sample followed by cellulose 
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B with 16.8 % and activated charcoal with 14.4%. All other agents recorded binding agents tested 
recorded efficacy of under 10% (range: 1.0 – 6.7%). Another challenge with these binders is that 
they are mostly non-selective and, in many instances, other nutrients such as vitamins, amino acids, 
and minerals are bound along with the mycotoxins. A suitable adsorbent material should be able 
to bind a wide range of toxins, have high adsorption potential, reduce the non-specific attraction 
for nutrient binding, and have properties similar to feed ingredients  (Zhu et al., 2016).  
 
2.6.2 Chemical methods of mitigating DON in feed ingredients and complete diets 
 The chemical methods of DON mitigation involve the use of chemical agents such as bases, 
acids, oxidizing agents, aldehydes, or bisulfite gases to alter the chemical structure or 
bioavailability of the toxin in the gut of the pig (Zhu et al., 2016). The chemical methods also 
included using gamma rays in a radioactive treatment which has been reported to be an efficient 
control for mycotoxins such as AF (Bhat et al., 2010). The use of gamma rays, however, does not 
seem to be feasible according to O’Neill et al. (1993) due to the high levels of irradiation required 
to destroy the toxin.  Zinc compounds (Savi et al., 2015) and ozonation (Chaytor et al., 2011; Savi 
et al., 2015) are effective against DON decontamination. The main limitation to the chemical 
means of controlling DON in diets arises from their general high specificity for DON. This makes 
it easy for DON to avoid decontamination due to masking by proteins and carbohydrate molecules 
(Berthiller et al., 2005; Warth et al., 2013) and could result in an unexpectedly high free-DON 
content even after applying these methods. Other limitations include the increased overall cost of 
acquiring and application of these products and their use in pork production. Further, the required 
regulatory requirements and consumer acceptance may pose a challenge to their implementation. 
 
2.6.3 Biological methods of mitigating DON in feed ingredients and complete diets 
 Biological methods for controlling DON, which includes the use of enzymes and 
microorganisms, such as bacteria and yeast (Dalié et al., 2010; Pizzolitto et al., 2012), seem to be 
the most desirable means of controlling DON, due to the high efficiency and specificity and low 
environmental impact (Zhu et al., 2016) of these methods. There are two main modes of action 
through which these biological methods reduce mycotoxins (Leibetseder, 2006). The first is the 
detoxification of mycotoxins and the prevention of the formation of secondary toxins (Leibetseder, 
2006). The use of intestinal bacteria from poultry and ruminants has shown some promise with 
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converting DON to its less toxic form DOM-1 (Leibetseder, 2006). Leibetseder (2006) further 
reported in a review that there was a 55% reduction in DON concentration when 5 mg/kg DON-
contaminated corn was treated with poultry digestive tract microbial inoculum, which also 
lessened the toxic effects on pigs. According to Awad et al. (2010), the effectiveness and 
economics will determine the practicality of using microorganisms for the catabolism and 
detoxification of DON in feed ingredients and feeds. In addition to the methods mentioned, other 
innovative methods include the use of essential oils (Luo et al., 2018), magnetic materials, and 
nano-particles (Chauhan et al., 2016; Luo et al., 2018). 
 
2.6.4 Combining mitigation strategies of DON in conventional feed additives  
A more recent strategy being examined to control the negative effects of mycotoxins is the 
use of feed additives which contain a blend of components, such as enzymes, probiotics, amino 
acids, antioxidants, adsorbents, aimed at detoxifying and binding mycotoxins in the feed as well 
as supporting animal health. For example, Van Le Thanh et al. (2015) reported that when four feed 
additives were tested for efficacy, diets containing preservation components showed promise of 
restoring the performance of pigs, whereas contaminated diets containing aluminosilicate (silicate 
clay), glucomannan (dietary fiber), yeast, live bacteria, enzymes, and plant extracts individually 
had no effect. The use of a commercially available preservative blend was also reported to be 
effective against DON in contaminated diets (Patience et al., 2014). While no feed additives have 
been approved in North America, specifically the U.S and Canada, for the control of DON in 
contaminated diets, there are some significant successes reported in Europe. Plank et al. (2009) 
reported that two products, Biomin® BBSH 797 and Mycofix Plus® 3.E, approved by the 
European Food Safety Authority were indeed capable of reducing the negative effects of DON on 
growing pigs but Sayyari et al. (2018) showed no effect when an additive with the bacterial strain 
Coriobacteriaceum DSM 11798 (the active component of Biomin® BBSH 797) was used in 
growing pigs. Other commercially available products include Defusion (Akey, Inc., Lewisburg, 
OH) or Integral (Alltech, Nicholasville, KY). With these varying results and a scarcity of 
information regarding the effectiveness of various mycotoxin products available commercially 
(Patience et al., 2014), further research on the development and use of feed additives to mitigation 
mycotoxins, and specifically DON, is required. 
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 In conclusion, the above review has outlined and established the reported effects of DON-
contaminated diets of swine and are now fairly known but over the short term mostly. The review 
also attempted to highlight some of the challenges surrounding DON contamination both in the 
grain and swine production sectors, as well as potential control and mitigation approaches 
available. However, when the increasing incidence of DON contamination is considered, there is 
an obvious economic impact of mycotoxin contamination for both the grain and pork sectors. 
Besides, with the lack of effective mitigation strategies, specifically for DON-contamination in 
diets for pigs in Canada, further information is required on more practical and feasible strategies 
such as the long-term DON exposure in grower-finisher pigs. Since production systems largely 
follow a long-term feeding regime, this information can be used to develop feeding programs that 
maximize the inclusion of DON-contaminated grains while minimizing the impact on growth 




2.7 Objectives and hypotheses 
The overall objective of this thesis was to determine the effects of long-term feeding of 
graded levels of DON in grower-finisher and finisher pigs.  
The specific objectives of the studies were to determine: 
1. The effects of DON levels on growth performance, nutrient utilization, and carcass 
characteristics. 
2. The effects of DON levels on the overall health status of pigs. 
3. The effects of DON levels on older pigs versus younger pigs. 
4. The effects of dietary DON on DON levels in biological samples from pigs fed DON. 
 
2.8 Research hypotheses 
1. Increasing DON intake will initially reduce performance and nutrient utilization, which 
will recover over time. There will, however, be no negative effects of DON intake on 
carcass characteristics.  
2. Increasing DON intake will result in negative effects on physiological indicators of health 
and immune function. 
3. Older pigs will not experience severe effects in response to increasing DON intake and will 
require a shorter adaptation period compared to younger pigs. 















3.0 MATERIALS AND METHODS 
The experimental protocols used in the present studies were reviewed and approved by the 
Animal Research Ethics Board of the University of Saskatchewan (AUP20130054) and followed 
the guidelines of the Canadian Council on Animal Care (CCAC, 2009). 
 
3.1 Animals, housing, diets, and experimental design  
3.1.1 Experiment 1 (finisher pigs) 
A total of 200 mixed-sex finishing pigs (Camborough Plus × C337; PIC., Canada) with 
initial body weight (BW) of 76.6 ± 3.9 kg were used in a 42-d experiment at the Prairie Swine 
Centre Inc. (Saskatoon, SK, Canada). The pigs were grouped-housed in pens (5 pigs/pen) in 
environmentally controlled rooms. The pens were randomly assigned to 1 of 4 dietary treatments 
(n=10 pens/treatment; Table 1). Dietary treatments consisted of a control diet (CONT) containing 
no DON or a diet containing 1, 3, or 5 ppm DON (DON1, DON3, or DON5). The basal diet was 
wheat-barley-soybean meal-based and formulated to be isonitrogenous and isoenergetic with 
nutrients meeting or exceeding the recommended requirement for finisher pigs (NRC, 2012). The 
dietary DON levels were achieved by replacing DON-free wheat with DON-contaminated wheat 
and wheat screenings proportionally according to the target DON levels. The mycotoxin profile 
and content of the DON-contaminated wheat and wheat screenings used in diet formulation were 
determined at Central Testing Laboratory (Winnipeg, MB, Canada). The complete experimental 
diets were analyzed for mycotoxins at Biomin Holding GmbH (Erber Campus 1, 3131 Getzersdorf, 
Austria; Table 2). The pigs had ad libitum access to feed and water. At the start of the growth 
performance trial, 1 barrow in each pen representing the average pen BW was selected for blood 
sampling and nitrogen (N)-balance. On the mornings of d 0, 14, and 42, blood samples were 
collected from the representative pig in each pen via jugular puncture while restrained with a hog 
holder. Blood samples were collected into heparin-coated and additive-free tubes (5 mL; BD 
vacutainer, BD, Mississauga, ON, Canada), which were temporarily stored on ice and then 
centrifuged at 2500 × g for 15 min to harvest plasma and serum, respectively. The plasma and 
serum samples were stored at -20 ℃ until further analysis. Serum samples were analyzed for DON 




Table 1 Composition of the diets used in experiment 1 (as-fed basis)1 
Ingredient, % CONT2 DON13 DON34 DON55 
Clean wheat 40.0 33.3 20.0 6.7 
DON wheat 6 0.0 4.9 14.8 24.7 
Wheat screenings7 0.0 1.7 5.2 8.6 
Barley 44.0 44.0 44.0 44.0 
Canola oil 3.5 3.5 3.5 3.5 
Soybean meal 10.0 10.0 10.0 10.0 
L-Lysine-HCl 0.30 0.30 0.30 0.30 
DL-Methionine 0.07 0.07 0.07 0.07 
L-Threonine 0.10 0.10 0.10 0.10 
Limestone 0.8 0.8 0.8 0.8 
Dicalcium phosphate 0.5 0.5 0.5 0.5 
Salt 0.5 0.5 0.5 0.5 
Vitamin/Mineral Premix8 0.2 0.2 0.2 0.2 
Calculated Nutrient Content     
ME, kcal/kg 3282 3282 3282 3282 
NE, kcal/kg 2502 2502 2502 2502 
Dry Matter, % 86.5 86.5 86.5 86.6 
Crude Protein, % 15.9 15.9 15.9 16.0 
Lysine, % SID9 0.76 0.76 0.76 0.76 
Calcium, % 0.50 0.50 0.50 0.50 
Phosphorus, % 0.48 0.48 0.48 0.48 
Analyzed Nutrient Content      
Growth performance diet     
Dry Matter, % 88.9 88.2 88.3 88.8 
Crude Protein, % 14.6 14.2 13.5 14.8 
DON10, ppm11 0.11 1.34 3.58 5.72 
Nitrogen Balance diet     
Dry Matter, % 88.5 88.1 88.9 88.7 
Crude Protein, % 14.5 14.6 14.1 14.7 
DON, ppm 1.56 1.32 3.09 4.94 
1Nutrient content of diets based on the nutrient content of feed ingredients according to NRC (2012). 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6DON wheat contains 6.9 ppm DON (Central Testing Laboratory, Winnipeg Manitoba). 
7Wheat screenings contain 32.8 ppm DON (Central Testing Laboratory, Winnipeg Manitoba). 
8Supplied per kg of complete diet; vitamin A, 8000 IU; vitamin D, 1500 IU; vitamin E, 30  IU; 
menadione, 2.5 mg; vitamin B12, 0.025 mg; thiamine, 1.00 mg; biotin, 0.10 mg; niacin, 20 mg; 
riboflavin, 4 mg; pantothenate; 12 mg; folic acid, 0.50 mg; pyridoxine, 2.0 mg; Fe, 100 mg; Zn, 100 mg; 
Mg, 40 mg; Cu, 15 mg; Se, 0.30 mg; and I, 1mg.  
9SID, standardized ileal digestibility 
10DON, deoxynivalenol content analyzed by BIOMIN  
11ppm, parts per million. 
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On d 35 of the experiment 1 pig/pen (identified at the start of the experiment) representing 
the average BW of the pen were individually housed in metabolism crates (56” × 58.5”) in a 
temperature-controlled room (21 ± 2 ℃) for N-balance collection. The selected pigs from the 
growth performance trial remained on the same dietary treatment during the N-balance period. 
During the N balance period, the same basal wheat-barley-soybean- diets were fed except for the 
inclusion of celite (0.4%) at the expense of uncontaminated wheat. The daily feed allocation was 
set at 2.8 × maintenance metabolizable energy requirement (197 kcal/kg BW0.60/d; NRC, 2012) 
and fed in two equal meals at 0700 h and 1500 h. Following a 7-d dietary and environmental 
adaptation period, total daily urine output and fresh-fecal grab samples were collected over a 2-d 
period. On the last day of the 2-d collection period, approximately 3-4 h post-prandial, blood 
samples were taken from pigs for serum DON analysis. 
 
3.1.2 Experiment 2 (grower-finisher pigs) 
A total of 240 grower-finisher pigs (Camborough Plus × C337; PIC., Canada) with an 
initial body weight of 35.9 ± 1.1 kg were used in a 77-d experiment at the Prairie Swine Centre 
Inc. (Saskatoon, SK, Canada). The pigs were group-housed in pens (6 pigs/pen) in environmentally 
controlled rooms (21 ± 2℃). The pens were randomly assigned to 1 of 4 dietary treatments 
(n=10/treatment; Table 2). Dietary treatments consisted of a control diet (CONT) containing no 
DON or a diet containing 1, 3, or 5 ppm DON (DON1, DON3, or DON5). Dietary DON content 
was achieved by replacing uncontaminated wheat with a proportional amount of DON-
contaminated wheat and wheat screenings to attain the targeted DON levels in the final diet. The 
mycotoxin content of wheat and wheat screenings used in formulating the experimental diets were 
analyzed using ELISA at Central Testing Laboratory (Winnipeg, MB, Canada). The basal diet was 
wheat-barley-soybean meal-based and formulated to be isonitrogenous and isoenergetic with 
nutrients meeting or exceeding the recommended requirement for grower (25-75 kg) and finisher 
pigs (75-120 kg) according to the NRC (2012). The diets were fed according to a 2-phase protocol, 
with grower phase diets fed from d 0 – 42 and finisher phase diets fed from d 43 – 77.  The pigs 
had ad libitum access to feed and water. At the beginning of the experiment, 2 pigs/pen were 
identified as representative pigs for the grower and finisher phases. On d 14 and d 56 of the 
experiment, the previously selected pigs in each pen were inoculated intramuscularly with a 
commercial vaccine to elicit a humoral response (Farrowsure® Gold, Serial No.: 316169Zoetis ) 
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against Leptospirosis caused by Leptospira canicola, Leptospira grippotyphosa, Leptospira 
hardjo, Leptospira icterohaemorrhagiae, and Leptospira pomona (Wunder Jr et al., 2020). Blood 
samples were taken before (d 0) and after the vaccine injections on d 14, 42, 56, and 84 via jugular 
puncture into both heparin-coated and additive-free tubes (5 mL; BD vacutainer, BD, Mississauga, 
ON, Canada), centrifuged at 2500 × g for 15 min for plasma and serum sample collection, 
respectively, which were stored at -20 ℃ until further analyses. 
On d 35 of the grower phase and d 77 of the finisher phase, the selected pigs (identified at 
the start of the experiment) representing the average BW of the pen were isolated and used for N-
balance collection. The pigs were individually housed in metabolism crates (56” × 58.5”) in a 
temperature-controlled room (21 ± 2 ℃) and assigned to the same dietary treatments as in the 
growth performance study. The same basal wheat-barley-soybean-based diets were used, except 
for the inclusion of celite (0.4%) at the expense of uncontaminated wheat. The daily feed allowed 
at 2.8 × maintenance net energy requirement (197 kcal/kg BW0.60/d; NRC, 2012) and fed in two 
equal meals at 0700 h and 1500 h. After a 7-d dietary and environmental adaptation period, total 
daily urine output and fresh-fecal grab samples were collected over a 2-d period. On the last day 
of the 2-d collection period, approximately 3-4 h post-prandial, blood samples were taken from 
pigs for serum DON analysis. Pigs used in the N-balance study were not returned to the trial after 
the N-balance was completed. 
 
3.2 Experimental procedure and analyses 
3.2.1 Growth performance (experiment 1 and 2) 
In both experiment 1 and 2, individual pig body weight and per pen feed intake was 
measured weekly for determination of average daily gain (ADG), average daily feed intake 
(ADFI), and feed efficiency (gain: feed; GF).   
 
3.2.2 Nitrogen-balance (experiment 1 and 2) 
During the sample collection days, urine jars containing sufficient HCl to maintain pH < 3 
(Columbus et al., 2014) were placed under the urine collection trays of each metabolism crate to 
collect urine samples over two 24 h periods. At the end of each 24-h period, urine was weighed, 
and a 5% aliquot was sampled and stored at -20℃. At the end of the 2-d sample collection period, 
urine samples were thawed and pooled for each pig, filtered with glass wool to remove any debris, 
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and a 5% subsample was obtained and stored at -20 oC until further analysis. Fresh fecal grab 
samples were taken daily by rectal palpation, pooled, homogenized at the end of the 2-d collection 
period, and a subsample stored at -20 ℃ until further analysis.  
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Table 2 Composition of the diets used in experiment 2 (as-fed basis)1 
Ingredient, % 
Grower Diet Finisher Diet 
CONT2 DON13 DON34 DON55 CONT DON1 DON3 DON5 
Clean wheat 40.0 33.3 20.0 6.7 40.0 33.3 20.0 6.7 
DON wheat 6 0.0 4.9 14.8 24.7 0.0 4.9 14.8 24.7 
Wheat 
screenings7 
0.0 1.7 5.2 8.6 0.0 1.7 5.2 8.6 
Barley 39.2 39.2 39.2 39.2 44.0 44.0 44.0 44.0 
Canola oil 3.7 3.7 3.7 3.7 3.5 3.5 3.5 3.5 
Soybean meal 14.0 14.0 14.0 14.0 10.0 10.0 10.0 10.0 
L-Lysine- HCl 0.46 0.46 0.46 0.46 0.30 0.30 0.30 0.30 
DL-Methionine 0.08 0.08 0.08 0.08 0.07 0.07 0.07 0.07 
L-Threonine 0.14 0.14 0.14 0.14 0.10 0.10 0.10 0.10 
Limestone 1.0 1.0 1.0 1.0 0.8 0.8 0.8 0.8 
Dicalcium 
phosphate 
0.8 0.8 0.8 0.8 0.5 0.5 0.5 0.5 
Salt 0.5 0.5 0.5 0.5 0.5 0.5 0.5 0.5 
Vitamin/Mineral 
Premix8 
0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 
Calculated nutrient content 
ME, kcal/kg 3291 3291 3291 3291 3282 3282 3282 3282 
NE, kcal/kg 2495 2495 2495 2495 2502 2502 2502 2502 
Dry Matter, % 86.4 86.4 86.4 86.5 86.5 86.5 86.5 86.6 
Crude Protein, % 17.5 17.5 17.5 17.5 15.9 15.9 15.9 16.0 
Lysine, % SID9 0.98 0.98 0.98 0.98 0.76 0.76 0.76 0.76 
Calcium, % 0.64 0.64 0.64 0.64 0.50 0.50 0.50 0.50 
Phosphorus, % 0.53 0.53 0.53 0.53 0.48 0.48 0.48 0.48 
Analyzed nutrient content 
Growth performance diet 
Dry Matter, % 89.2 88.4 82.9 89.4 90.5 90.2 86.7 90.2 
Crude Protein, % 15.4 17.4 16.4 16.4 16.7 16.3 17.2 16.6 
DON10, ppm11 0.28 0.73 3.40 4.36 0.20 1.02 3.28 4.14 
Nitrogen balance diet 
Dry Matter, % 88.9 89.4 88.8 88.6 90.1 90.1 90.5 90.3 
Crude Protein, % 17.8 18.8 18.2 17.3 16.0 15.7 16.5 16.5 
DON, ppm 0.04 0.57 2.72 4.10 1.04 1.35 3.28 5.43 
1Nutrient content of diets based on the nutrient content of feed ingredients according to NRC (2012). 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6DON wheat contains 6.9 ppm DON (Central Testing Laboratory, Winnipeg Manitoba) 
7Wheat screenings contain 32.8 ppm DON (Central Testing Laboratory, Winnipeg Manitoba) 
8Supplied per kg of complete diet; vitamin A, 8000 IU; vitamin D, 1500 IU; vitamin E, 30  IU; menadione, 
2.5 mg; vitamin B12, 0.025 mg; thiamine, 1.00 mg; biotin, 0.10 mg; niacin, 20 mg; riboflavin, 4 mg; 
pantothenate; 12 mg; folic acid, 0.50 mg; pyridoxine, 2.0 mg; Fe, 100 mg; Zn, 100 mg; Mg, 40 mg; Cu, 15 
mg; Se, 0.30 mg; and I, 1mg 
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9SID, standardized ileal digestibility 
10DON, deoxynivalenol content analyzed by BIOMIN using high-performance liquid chromatography with 
tandem mass spectrometry (HPLC-MS/MS) based analysis 









3.2.3 Analysis of feed, fecal, and urine samples (experiment 1 and 2) 
The dry matter (DM) content of the diet and fecal samples and were analyzed in duplicate 
(AOAC, 2007; Method 930.15).  The N content in the diet, feces, and urine were analyzed using 
an automatic analyzer (LECO FP 528; MI; USA;  AOAC, 2007; Method 990.03). The acid-
insoluble ash (AIA) content of both diet and fecal samples were analyzed according to the method 
described previously (Van Keulen and Young, 1977). Nitrogen retention was calculated as the 
difference between nitrogen intake and nitrogen output (urine and fecal). 
 
3.2.4 Serum chemistry panel analysis (experiment 1 and 2) 
Serum samples were analyzed for key indicators of liver and kidney function and health 
using an automatic blood chemistry analyzer according to established methods (Prairie Diagnostic 
Services, Saskatoon, SK, Canada).  
 
3.2.5 Deoxynivalenol analysis in diet, serum, and urine samples (experiment 1 and 2) 
All mycotoxin analysis was performed in the laboratory of Biomin Holding GmbH (Erber 
Campus 1, 3131 Getzersdorf, Austria). An analytical standard for deoxynivalenol (DON) was 
acquired commercially (Romer Labs GmbH, Tulln, Austria). β-glucuronidase (Escherichia coli, 
Type IX-A) and PBS buffer were obtained from Sigma-Aldrich (Vienna, Austria), methanol 
(MeOH), and acetic acid from VWR International (Vienna, Austria), and acetonitrile from Chem-
Lab NV (Zedelgem, Belgium). For the direct quantification of DON in diet, urine, and serum 
samples, high-performance liquid chromatography with tandem mass spectrometry (HPLC-
MS/MS) based analysis was performed according to the method described by Schwartz-
Zimmermann et al., 2017. DON recovery per milliliter of urine and serum was based on actual 
intake. 
For serum samples, indirect quantification of DON was performed. To this end, samples 
were analyzed both with and without β-glucuronidase pre-treatment. One hundred microliters of 
serum samples without β-glucuronidase was added to 200 µL of MeOH/acetic acid (99.8/0.2, v/v), 
shaken for 1 hour on a vortex shaker, and centrifuged (19.000 rcf, 20 min). Afterward, 200 µL of 
the supernatant was transferred into an HPLC vial and subjected to HPLC-MS/MS analysis. For 
enzymatic hydrolysis, 35 mg of β-glucuronidase was dissolved in 2.5 mL PBS and added at 50 µL 
per 100 µL serum. After incubation for 18 h (37° C, 80 rpm), 300 µL of MeOH/acetic acid 
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(99.8/0.2, v/v) were added. Subsequent shaking and centrifugation steps were performed as 
described above. The determination of analytes was performed on a QTRAP 6500 using an HPLC-
MS/MS-based method described previously (Schwartz-Zimmermann et al., 2017). Samples were 
measured in duplicate and quantified using matrix-matched samples. To this end, urine samples 
from the control group were spiked with the standard compound at six spiking levels (0.5 – 100 
ppb for DON). 
 
3.2.6 Serum IgG titer analysis (experiment 2) 
Blood serum was analyzed for Leptospira antibody ELISA according to Wilson-Welder et 
al. (2020) at the Vaccine and Infectious Disease Organization - International Vaccine Centre 
(Saskatoon, SK, Canada). Briefly, the detection of the immunoglobulin G (IgG) against Leptospira 
spp in pig serum was completed in a reconstituted Leptospira vaccine (Vanguard® L4, Zoetis 
Canada Inc., Kirkland, QC).  Following that, a protein assay was completed to determine the 
protein concentration. The vaccine antigen was diluted to 10 µg/mL in a carbonate-bicarbonate 
buffer (pH 9.6), applied to Immulon plates (Thermo Fisher Scientific, Mississauga, ON, Canada) 
at 100 µL per well, covered, and incubated overnight at 4 ℃. The plates were subsequently washed 
with 300 µL per well four times with Tris-buffered saline containing 0.05% Tween 20 (TBST). 
The serum samples were diluted (13 µL + 120 µL TBST) and four-fold serial dilutions across the 
plate for 6 wells, including a negative and positive control for each plate, and incubated for 2 h at 
room temperature. Plates were washed again with TBST and 100 µL of KPL Goat anti-Swine IgG 
(H+L) phosphatase labeled affinity purified antibody (catalog KP-15-14-06, Invitrogen, Life 
Technologies Inc., Burlington, ON, Canada) added at a dilution of 1/5000 in TBST and allowed 
to incubate at room temperature for 1h. Plates were further washed and p-nitrophenyl phosphate 
di(tris) salt crystalline (PNPP) (Sigma N3254, St. Louis, Missouri, United States) substrate was 
added at 100 µL per well and incubated for 2.5 h. Finally, the reaction was stopped by adding 30 
µL 2N H2SO4 per well and the plate read at 405 nm, reference 490 nm on a SpectraMaxplus 
microplate ELISA reader (Molecular Devices, Sunnyvale, CA, USA) (da Cunha et al., 2019). The 





3.2.7 Carcass quality analysis (experiment 2) 
On d 77, all pigs were transported to a commercial abattoir (Maple Leaf Foods, Brandon, 
MB, Canada) for slaughter and collection of carcass characteristic data, including slaughter weight 
(SW), backfat thickness (BFT), loin depth (LD), and overall lean yield for further analysis to assess 
the impact of DON on carcass yield and quality. Pigs were tattooed on a per pen basis before 
transporting to the packing plant. Only data for pigs correctly identified by tattoo numbers at the 
packing plant were utilized in the carcass analysis for increased confidence in the data even though 
the significant amount of data lost may also affect the results.  
 
3.3 Statistical analyses 
All data were verified for normality using the PROC UNIVARIATE (SAS Institute, Cary, 
NC, Version 9.4) and outliers were tested using the studentized residual analysis (values 3 standard 
deviation from the mean were considered outliers). The growth performance and nitrogen balance 
data were analyzed as a randomized complete block design with the fixed effect of dietary 
treatments (CONT, DON1, DON3, and DON5) and block (room) as the random variable (PROC 
MIXED, SAS Institute, Cary, NC, Version 9.4). The immune response data and blood chemistry 
analyses were analyzed as a repeated measure with ‘day’ as a repeated variable. Regression 
analysis was used to describe relationships between DON intake and ADG, total BW gain, urinary, 
and blood DON (PROC REG, SAS Institute, Cary, NC, Version 9.4). Significance was determined 
at P < 0.05. A trend towards significance was considered at P ≤ 0.10. When significance is 




4.1 Dietary DON level in experimental diets (Expt. 1 and Expt. 2) 
Before the start of the study, the mycotoxin profile was analyzed for DON-contaminated 
ingredients utilized (wheat and wheat screenings) (data not shown) to allow for the appropriate 
formulation of DON levels in the experimental diets. Subsequently, the preliminary diets 
formulated were also analyzed for the mycotoxin profile and concentration and also showed 
similar levels of DON as the calculated formulation (data not shown).  
Diet samples collected during the study analyzed after completion of the study showed that 
the levels of DON were mostly within the formulated range except for the diets used for the N-
balance study for both Expt. 1 (Table 3) and Expt. 2 (Table 4 and 5). 
 




Growth Performance Diets Nitrogen-Balance Diets 
CONT2 DON13 DON34 DON55 CONT DON1 DON3 DON5 
DON6 0.11 1.34 3.59 5.72 1.56 1.32 3.09 4.94 
3 ADON7 ND9 ND ND ND ND ND ND ND 
15 ADON8 ND ND ND ND ND ND ND ND 
HT-2 toxin ND ND ND 0.05 ND ND ND 0.03 
Nivalenol 0.15 0.18 0.53 0.64 0.12 0.11 0.12 0.08 
Ochratoxin A 0.01 0.03 0.01 0.01 0.01 0.03 0.07 0.09 
Zearalenone ND 0.002 0.009 0.014 0.003 0.002 0.009 0.013 
Ergot 
alkaloids 
0.99 0.57 1.03 1.26 0.24 0.16 0.39 0.67 
1Mycotoxin contents analyzed in diet samples by BIOMIN. All other mycotoxins were below harmful 
levels. These diets were made independently but from the same batch of ingredients 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6DON, deoxynivalenol 
73 ADON, 3-acetyldeoxynivalenol 
815 ADON, 15-acetyldeoxynivalenol 
9ND, Not detected or below the limit of detection. 
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Table 4 Analyzed mycotoxin levels (ppm) in grower diets used in experiment 2 (as-fed basis)1 
Mycotoxin, 
ppm 
Grower Phase Diets 
Growth Performance Diets Nitrogen-Balance Diets 
CONT2 DON13 DON34 DON55 CONT DON1 DON3 DON5 
DON6 0.28 0.73 3.40 4.36 0.04 0.57 2.72 4.10 
3 ADON7 ND9 ND ND ND ND ND ND ND 
15 ADON8 ND ND ND ND ND ND ND ND 
HT-2 toxin ND ND ND ND ND ND ND ND 
Nivalenol 0.39 0.30 0.17 0.33 0.06 0.20 0.08 0.09 
Ochratoxin A 0.01 0.01 0.03 0.02 ND 0.01 0.06 0.10 
Zearalenone ND ND 0.01 <0.01 ND ND <0.01 0.01 
Ergot 
alkaloids 
0.53 0.73 1.13 0.69 1.01 0.63 0.98 1.78 
1Mycotoxin content analyzed in diet samples by BIOMIN using high-performance liquid chromatography 
(HPLC) with tandem mass spectrometry (MS/MS) (HPLC-MS/MS) based analysis 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6DON, deoxynivalenol 
73 ADON, 3-acetyldeoxynivalenol 
815 ADON, 15-acetyldeoxynivalenol 















Table 5 Analyzed mycotoxin levels (ppm) in finisher diets used in experiment 2 (as-fed basis)1 
Mycotoxin, ppm 
Finisher Phase Diets 
Growth Performance diets Nitrogen-Balance diets 
CONT2 DON12 DON34 DON55 CONT DON1 DON3 DON5 
DON6 0.20 1.02 3.28 4.13 1.04 1.35 3.22 5.43 
3 ADON7 ND9 ND 0.03 0.04 ND ND ND 0.02 
15 ADON8 ND ND ND ND ND ND ND ND 
HT-2 toxin ND ND ND ND ND ND ND 0.04 
Nivalenol 0.53 0.63 0.55 0.16 0.10 0.09 0.12 0.09 
Ochratoxin A ND 0.02 0.02 0.07 0.01 0.03 0.09 0.12 
Zearalenone 0.001 0.004 0.004 0.007 0.006 0.004 0.008 0.014 
Ergot alkaloids 0.32 0.63 0.61 0.36 0.18 0.20 0.28 0.77 
1Mycotoxin content analyzed in diet samples by BIOMIN using high-performance liquid chromatography 
(HPLC) with tandem mass spectrometry (MS/MS) (HPLC-MS/MS) based analysis 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6DON, deoxynivalenol 
73 ADON, 3-acetyldeoxynivalenol 
815 ADON, 15-acetyldeoxynivalenol 








4.2 Experiment 1 (finisher pigs) 
4.2.1 Growth performance  
Growth performance data are presented in Table 6.  Bodyweight was reduced in DON3 
and DON5 fed pigs by d 7, with the greatest reduction observed in DON5 fed pigs (P > 0.05). This 
reduction in BW was consistently observed throughout the experiment. The ADG in DON1 fed 
pigs was not different from pigs receiving the CONT diet (P > 0.05). From d 0-7, DON3 fed pigs 
had reduced growth compared to both CONT and DON1 fed pigs (P < 0.05), which was not 
different from CONT fed pigs from d 8-42 (P > 0.05). Pigs fed DON5 had reduced ADG from d 
0-21 compared to all other dietary treatments (P < 0.05). From d 22-28, ADG of DON5 fed pigs 
was not different than DON1 and DON3 fed pigs (P > 0.05). From d 29-42, there were no 
differences in ADG among dietary treatments (P > 0.05). Overall (d 0-42), ADG was reduced in 
DON3 and DON5 fed pigs compared to both CONT and DON1, with the greatest reduction 
observed with DON5 (P < 0.05). There was no impact of DON1 on ADFI compared to CONT (P 
> 0.05). From d 0-7, DON3 fed pigs had reduced ADFI compared to both CONT and DON1 fed 
pigs (P < 0.05), after which no difference was observed (P > 0.05). In DON5 fed pigs, ADFI was 
reduced from d 0-28 compared to all other dietary treatments (P < 0.05), after which no difference 
was observed (P > 0.05). Overall (d 0-42), ADFI was only reduced in DON5 fed pigs (P < 0.05). 
Feed efficiency, measured as GF, was reduced in DON5 fed pigs from d 0-7 compared to all other 
dietary treatments (P < 0.05), which were not different from each other (P > 0.05). There was no 
effect of dietary treatment on GF from 8-42 or overall (d 0-42; P > 0.05).   
 
4.2.2 Relationship between dietary DON intake and body weight gain  
A linear regression model was applied to examine the relationship between DON intake 
and growth (% BW gain, Fig. 1; ADG, Fig. 2). For this analysis, the BW gain of all DON-
contaminated treatments (DON1, DON3, and DON5) was compared to the average BW gain of 
the CONT pigs. As indicated, there was a negative relationship between DON intake and BW gain, 
when DON intake increased, % BW gain was reduced. This negative relationship was also 
observed for ADG, such that as DON intake increased, a linear reduction in ADG was observed. 
This relationship was consistent from d 0-35, however, the strength of the impact of DON intake 
on ADG was reduced (P < 0.05) consistently and from d 28-35, the impact was lowest, with a 
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slope not different from zero (P > 0.05; Fig.2E). From d 35-42, the slope shows a positive 
relationship (Fig. 2F).  
 
Table 6 Growth performance of finisher pigs fed graded levels of deoxynivalenol1 
Dietary Treatments 
Items CONT2 DON13 DON34 DON55 SEM6 P-value 
Body Weight, kg 
   Initial      76.9 77.0 76.3     76.0 1.18 NS7 
   Day 7 85.4a 84.8a 83.0b 80.8c 0.34 <0.001 
   Day 14 95.3a 95.3a 92.4b 88.7c 0.42 <0.001 
   Day 21 103.4a 103.8a 99.8b 95.7c 0.50 <0.001 
   Day 28 112.1a 111.9a 107.8b  103.0c 0.53 <0.001 
   Day 35 119.7a 119.8a 114.9b  110.4c 0.63 <0.001 
   Final 126.7a 126.9a 123.6b  118.5c 0.80 <0.001 
Average daily gain, kg/d 
   Day 0-7 1.27a 1.18a 0.93b  0.60c 0.05 <0.001 
   Day 8-14  1.40ab 1.49a 1.33b  1.13c 0.04 <0.001 
   Day 15-21  1.17ab 1.21a 1.06b  1.01c 0.04   0.004 
   Day 22-28 1.24a   1.17ab  1.15ab  1.04b 0.04  0.033 
   Day 29-35     1.08 1.12      1.01 1.06 0.04 NS 
   Day 36-42     1.06 1.00 1.20 1.14 0.06 NS 
   Overall (d 0-42) 1.19a 1.20a  1.12b  1.00c 0.02 <0.001 
Average daily feed intake, kg/d 
   Day 0-7 2.59a 2.59a 2.22b 1.70c 0.06 <0.001 
   Day 8-14 2.98a 3.07a 2.89a 2.55b 0.07 <0.001 
   Day 15-21 3.03a 3.03a 2.88a 2.56b 0.05 <0.001 
   Day 22-28 3.25a 3.19a 3.13a 2.85b 0.05 <0.001 
   Day 29-35 3.22 3.20 3.19 3.04 0.06 NS 
   Day 36-42 3.19 3.11 3.36 3.05 0.08 NS 
   Overall (d 0-42) 2.99a 3.06a 2.94a 2.60b 0.05 <0.001 
Gain: Feed, kg/kg 
   Day 0-7  0.49a   0.46a  0.41a  0.34b 0.02 <0.001 
   Day 8-14 0.47 0.49 0.47 0.44 0.01 NS 
   Day 15-21 0.38 0.40 0.37 0.40 0.01 NS 
   Day 22-28 0.38 0.36 0.37 0.36 0.02 NS 
   Day 29-35 0.33 0.35 0.32 0.35 0.01 NS 
   Day 36-42 0.33 0.32 0.36 0.37 0.01 NS 
   Overall (d 0-42) 0.40 0.39 0.38 0.38 0.01 NS 
1Values are least-squares means (n=10 pens/treatment). Data were analyzed as a randomized complete 
block design. Differences between treatment means were determined using the Tukey-Kramer mean 
separation test with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10.  
2CONT, 0 ppm DON Control diet 
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3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6SEM, Standard error of means 
7NS, Not significant (P > 0.05) 










Figure 1 Regression analysis showing the relationship between deoxynivalenol (DON) intake and 
body weight change (%) relative to control (no DON) fed pigs. Each data point represents a pen 
(n=10 pens/treatment). Data expressed as the DON intake (mg/d) based on average daily feed 
intake (ADFI) and the bodyweight change of the DON treated groups relative to the control 
(CONT) group of pigs. The coefficient of determination (R2) of the regression curve is 0.55 at P 
< 0.05. 


















































            
 
Figure 2 Regression analysis showing the relationship between deoxynivalenol (DON) intake and average daily gain (ADG) in 
finisher pigs from d 0-7 (A), d 8-14 (B), d 15-21 (C), d 22-28 (D), d 29-35 (E), and d 36-42 (F). Each point on the graph represents an 
experimental pen (n=10 pens/treatment). Data are expressed as the DON intake (mg/d) based on average daily feed intake and the 
average daily gain (ADG). The coefficient of determination (R2) of the regression curve is 0.60, 0.41, 0.15, 0.20, 0.10, and 0.13 
respectively for A, B, C, D, E, and F, respectively, at P < 0.05.










































































































4.2.3 Nitrogen-balance  
The results for the N-balance are presented in Table 7.  Average daily N intake for pigs fed 
DON3 and DON5 were not different but both were lower (P < 0.05) than DON1 and CONT diet. 
The urinary N output from CONT, DON3, and DON5 diets were not different (P > 0.05) but the 
pigs fed DON1 had lower (P < 0.05) urinary N output compared to DON3 and CONT but not 
different from DON5. The fecal N output was not different between DON1, DON3, and DON5, 
but was higher (P < 0.05) in the CONT diet. The apparent total tract digestibility (ATTD) of N 
was lower (P < 0.05) in the CONT diet compared to all the other dietary treatments. The protein 
deposition (PD) for DON1 pigs, which received the lowest DON content in their diets, was higher 
(P < 0.05) than pigs fed CONT, DON3, and DON5 diets.  
 
4.2.4 Liver and kidney metabolites  
Key indicators of kidney and liver health and function are presented in Table 8. There was 
no effect (P > 0.05) of dietary DON content on the selected liver and kidney blood parameters. 
For most of the analyzed metabolites there was a significant effect of day, except for potassium 
and creatine kinase, which tended to be different (P = 0.075 and 0.073, respectively), and gamma-
glutamyl transferase, which was not affected (P > 0.05) by day.  These differences are considered 
to not be related to dietary treatment as there was no significant diet × day interaction. 
 
4.2.5 Concentration of DON in serum and urine  
A linear regression model was used to analyze the relationship between DON intake and 
DON and DON metabolite concentration in blood serum and recovery in urine as shown in Fig. 3, 
4, and 5. As dietary DON intake increased, the amount of DON in the blood increased. For urinary 
DON analysis, as dietary DON levels increased, there was an increase (P < 0.05) in DON in the 
urine. DON1 pigs also showed lower (P = 0.02) DON recovery in urine compared to DON3 but 
not different from DON5.  
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Table 7 Nitrogen-balance in pigs fed diets containing graded levels of deoxynivalenol for 42 d 1 
                      Dietary Treatments 
Items CONT2 DON13 DON34 DON55 SEM6 P-value 
N7 intake, g/d 67.84a 68.45a 63.48b 63.32b 1.27 0.024 
ATTD8 of N, % 79.27a 87.12b 85.41b 85.44b 1.56 0.009 
Urinary N output, g/d 25.53a 15.19b 28.38a 22.69ab 3.59 0.015 
Fecal N output, g/d 14.10a 8.82b 9.28b 9.26b 1.05 0.005 
N retained, g/d 28.30b 44.40a 25.85b 31.34b 3.17 <0.001 
N retained, % 41.68b 65.12a 40.62b 49.64b 4.75 <0.001 
Protein deposition9, g/d 176.89b 277.78a 161.56b 195.99b 19.81 <0.001 
1Values are least-squares means (n=10 pens/treatment). Data were analyzed as a randomized complete 
block design. Differences between treatment means were determined using the Tukey-Kramer mean 
separation test with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10. 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6 SEM, Standard error of means. 
7N, nitrogen 
8ATTD, Apparent total tract digestibility 
9Protein deposition = N retained × 6.25  







Table 8 Serum chemistry panel for liver and kidney metabolites1 




Diet Day Diet × Day 
Sodium, mM 0 144.4 144.1 144.5 144.5 0.70    
 14 146.2 145.9 146.1 145.8 0.70 NS7 <.001 NS 
 42 145.0 146.3 145.9 145.2 0.70    
Potassium, mM 0 5.45 5.42 5.35 5.60 0.18    
 14 5.32 5.05 5.01 5.44 0.18 NS NS NS 
 42 5.21 5.32 5.28 5.32 0.18    
Chloride, mM 0 97.4 97.9 97.3 97.4 0.70    
 14 98.9 99.7 99.1 99.6 0.70 NS <.0001 NS 
 42 98.8 99.9 99.6 98.9 0.70    
Bicarbonate, mM 0 26.8 26.9 28.4 27.3 0.71    
 14 31.1 29.3 29.3 28.8 0.71 NS <.0001 NS 
 42 33.4 32.3 33.1 32.2 0.71    
Anion Gap, mM 0 25.9 24.4 24.2 25.4 1.03    
 14 21.6 21.9 22.7 22.9 1.03 NS <.0001 NS 
 42 18.1 19.4 18.4 19.5 1.03    
Calcium, mM 0 2.84 2.78 2.82 2.86 0.05    
 14 2.82 2.74 2.74 2.80 0.05 NS 0.01 NS 
 42 2.75 2.95 2.92 2.88 0.05    
Phosphorus, mM 0 2.99 2.97 3.03 3.00 0.90    
 14 3.05 3.06 3.05 3.14 0.90 NS <.0001 NS 
 42 2.52 2.52 2.54 2.58 0.90    
Magnesium, mM 0 0.94 0.90 0.93 0.94 0.02    
 14 0.90 0.90 0.89 0.90 0.02 NS <.0001 NS 
 42 0.84 0.84 0.84 0.85 0.02    
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Table 8 (continued) Serum chemistry panel for liver and kidney metabolites1  
Urea, mM 0 4.03 3.96 3.64 3.70 0.30    
 14 4.74 4.40 4.09 4.12 0.30 NS <.0001 NS 
 42 4.91 4.81 5.00 4.67 0.30    
Creatinine, mM 0 112.4 113.6 111.9 114.5 4.60    
 14 118.5 118.9 116.8 122.3 4.60 NS <.0001 NS 
 42 136.6 139.4 134.9 140.6 4.60    
Glucose, mM 0 5.53 5.68 5.83 5.86 0.18    
 14 5.54 5.30 5.45 5.44 0.18 NS 0.05 NS 
 42 5.34 5.69 5.65 5.21 0.18    
Total Bilirubin, mM 0 1.10 1.10 1.09 1.17 0.10    
 14 0.72 0.84 0.86 0.73 0.10 NS <.0001 NS 
 42 0.39 0.50 0.43 0.44 0.10    
Direct Bilirubin, mM 0 0.44 0.38 0.42 0.37 0.04    
 14 0.27 0.27 0.25 0.25 0.04 NS <.0001 NS 
 42 0.25 0.33 0.25 0.28 0.04    
Indirect Bilirubin, mM 0 0.65 0.73 0.67 0.79 0.10    
 14 0.44 0.58 0.61 0.47 0.10 NS <.0001 NS 
 42 0.13 0.18 0.18 0.15 0.10    
GGT8, mM 0 39.7 36.8 41.6 38.9 3.40    
 14 36.9 35.5 37.2 42.3 3.40 NS NS NS 
 42 34.5 34.5 37.9 38.9 3.40    
GLDH9, mM 0 1.7 1.6 1.4 1.3 0.38    
 14 1.9 1.7 2.0 2.8 0.38 NS <.01 NS 
 42 1.2 1.2 1.2 1.2 0.38    
AST10, mM 0 30.3 28.2 23.0 25.9 3.10    
 14 25.6 29.3 25.5 33.5 3.10 NS <.0001 NS 




Table 8 (continued) Serum chemistry panel for liver and kidney metabolites1 
CK11, mM 0 3134 1559 144 2035 698.4    
 14 2545 3315 2208 3615 698.4 NS NS NS 
 42 2579 1885 1116 2390 698.4    
Total Protein, mM 0 68.0 63.9 63.3 64.1 1.70    
 14 65.4 63.7 60.7 63.6 1.70 NS <.01 NS 
 42 63.4 61.9 61.7 63.3 1.70    
Albumin, mM 0 43.1 42.0 42.4 43.7 0.90    
 14 41.4 41.5 41.0 42.3 0.90 NS 0.005 NS 
 42 42.0 43.0 43.3 43.5 0.90    
Globulin, mM 0 24.9 21.9 20.9 20.4 1.90    
 14 24.0 22.2 19.7 21.3 1.90 NS 0.001 NS 
 42 21.4 18.9 18.3 19.8 1.90    
Albumin:Globulin, mM 0 1.93 2.04 2.14 2.18 0.18    
 14 1.9 2.0 2.2 2.0 0.18 NS 0.002 NS 
  42 2.1 2.4 2.5 2.3 0.18    
1Values are least-squares means (n=10/treatment); DON, deoxynivalenol. The data was analyzed as a repeated measure with ‘day’ as the repeated 
variable. Significance determined at P < 0.05 and a trend towards significant at 0.05 < P < 0.10.   
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6 SEM, Standard error of means. 
7NS, Not significant (P > 0.05) 
8GGT, Gamma-glutamyltransferase 
9GLDH, Glutamate dehydrogenase 
10AST, Aspartate aminotransferase 










Figure 3 Regression analysis of the relationship between deoxynivalenol (DON) intake and serum 
DON concentration (ng/mL). The blood samples were taken during the nitrogen balance period 
(3-4 hours after a single meal) of the experiment and analyzed for DON concentration (n=10 
pigs/treatment). Data are expressed as the DON intake after a single meal and the serum DON 
concentration (ng/mL) after that meal. The coefficient of determination (R2) of the regression 












































Figure 4 Regression analysis of the relationship between deoxynivalenol (DON) intake and DON 
output in urine (n=10 pigs/treatment).The urine samples were collected during the nitrogen balance 
period of the experiment over 24-h and analyzed for DON content. Data are expressed as the DON 
intake per day (mg/d) and the urine DON output (mg/d) and the coefficient of determination (R2) 









































                                                                                                         
 
Figure 5 Deoxynivalenol (DON) recovery in urine expressed as a percentage of DON intake per 
pig per d in finisher pigs fed diets containing 1, 3, or 5 ppm DON (DON1, DON3, DON5, 
respectively). Bars represent urinary DON recovery shown as least square means ± SEM (n=10 
pigs/treatment). Differences between treatment means were determined using the Tukey-Kramer mean 




































4.3 Experiment 2 (grower-finisher pigs) 
4.3.1 Growth performance and carcass characteristics 
The growth performance results are presented in Table 9. The initial BW was not different 
(P > 0.05) between the dietary treatments. Pigs fed DON5 had reduced BW by d 21 and DON3 
fed pigs by d 35 compared to CONT fed pigs (P < 0.05) and in general this observation remained 
for the duration of the study.  There was no difference in BW between CONT and DON1 at any 
point (P > 0.05). From d 0-7, the ADG for pigs fed the DON3 and DON5 diets were lower (P < 
0.05) than DON1 and CONT fed pigs.  No effect (P > 0.05) of increasing dietary DON levels on 
ADG was observed from d 7-42. From d 42-49, ADG for pigs fed the DON5 diet was reduced (P 
> 0.05) compared to the other dietary treatments. Subsequently, no further treatment effects were 
observed (P > 0.05) on ADG from d 49-77. Only pigs fed the DON5 and DON3 diets had reduced 
ADG compared to CONT but no difference in ADG between DON1 entire grower phase (d 0-42) 
and no treatment differences observed over the entire finisher phase (d 42-77). Over the entire 
growth performance period (d 0-77), both DON3 and DON5 resulted in reduced ADG (P < 0.05) 
compared to both CONT and DON1, which were not different (P > 0.05).  
From d 0-7, the ADFI of pigs fed the DON5 diet was lower (P < 0.05) compared to pigs 
fed CONT, DON1, and DON3 diets. From d 7-21, there was no impact on dietary treatment (P > 
0.05) on ADFI. However, from d 21-28, pigs fed DON-contaminated diets (DON1, DON3, and 
DON5) had a significantly higher ADFI (P < 0.05) compared to the CONT fed pigs. From d 28-
42, no significant differences in ADFI were observed (P > 0.05). Over the entire grower period (d 
0-42) there was no impact of diet on ADFI (P < 0.05) whereas in the finisher period (d 42-77), 
feeding of DON-contaminated diets reduced ADFI compared to CONT (P < 0.05). Over the entire 
growth performance study, ADFI was reduced (P < 0.05) in DON3 and DON5 fed pigs compared 
to CONT and DON1, which were not different (P > 0.05). There was no impact of dietary treatment 
on GF (P > 0.05). Carcass characteristics data are presented in Table 10. There was no significant 






Table 9 Growth performance of grower-finisher pigs fed diets with graded levels of 
deoxynivalenol1 
 CONT2 DON13 DON34 DON55 SEM6 P-value 
Bodyweight, kg 
   Initial 36.0 35.6 35.7 36.4 0.34  NS7 
   Day 7      42.5 41.6 40.7 41.7 0.44 NS 
   Day 14 50.1a 49.8a 47.8b  49.2ab 0.49 0.010 
   Day 21 58.0a 57.7a  55.7ab 56.7b 0.60 0.040 
   Day 28 68.1 67.6 65.4 65.7 0.84 NS 
   Day 35 75.9a 74.5ab 72.7b 72.7b 0.86    0.030 
   Day 42 85.2a 83.7ab 81.9b 81.6b 0.91    0.030 
   Day 49 94.7a 93.1ab 90.9bc 89.8c 0.96 0.005 
   Day 56 102.7a 100.9ab 98.3bc 97.7c 1.00 0.004 
   Day 63 110.6a 108.6ab 106.3bc 105.0c 0.91 0.001 
   Day 70 118.4a 116.2ab 114.6bc 112.9c 0.91 0.001 
   Final 124.9a 123.0ab 121.0bc 120.0c 0.91 0.002 
Average daily gain, kg/d 
   Day 0-7 0.92a 0.86a 0.72b 0.76b 0.04 0.001 
   Day 8-14 1.09 1.17 1.02 1.08 0.04 NS 
   Day 15-21 1.14 1.13 1.12 1.06 0.03 NS 
   Day 22-28 1.44 1.42 1.38 1.30 0.06 NS 
   Day 29-35 1.15 1.12 1.14 1.11 0.04 NS 
   Day 36-42 1.32 1.32 1.32 1.27 0.04 NS 
   Day 43-49 1.37a 1.34a 1.28a 1.17b 0.04 0.010 
   Day 50-56 1.13 1.11 1.05 1.13 0.06 NS 
   Day 57-63 1.13 1.11 1.15 1.04 0.05 NS 
   Day 63-70 1.13 1.08 1.18 1.13 0.04 NS 
   Day 71-77 0.93 1.03 0.91 1.00 0.06 NS 
   Day 0-42 1.17a 1.15ab 1.10bc 1.08c 0.02 0.010 
   Day 43-77 1.14 1.13 1.11 1.10 0.01 NS 




Table 9 (continued) Growth performance of grower-finisher pigs fed diets with graded levels 
of deoxynivalenol1 
Average daily feed intake, kg/d 
   Day 0-7 1.59a 1.55a 1.40b 1.42b 0.04 0.002 
   Day 8-14 1.90 1.98 1.78 1.81 0.07 NS 
   Day 15-21 2.03 1.95 1.93 1.95 0.06 NS 
   Day 22-28 2.37b 2.58a 2.49a 2.49a 0.03 0.002 
   Day 29-35 2.79 2.77 2.67 2.60 0.05 NS 
   Day 36-42 3.17 3.07 3.09 2.95 0.08 NS 
   Day 43-49 3.17a 2.95a 2.96a 2.71b 0.08 0.004 
   Day 50-56 3.19a 3.06ab 2.99b 2.94b 0.06 0.01 
   Day 57-63 3.02 2.80 2.89 2.88 0.09 NS 
   Day 63-70 3.19 3.05 3.06 2.97 0.05 NS 
   Day 71-77 3.05 2.99 2.94 2.91 0.07 NS 
   Day 0-42 2.29 2.27 2.20 2.18 0.03 NS 
   Day 43-77 3.12a 2.97b 2.96b 2.88b 0.05 0.001 
Overall (d 0-77) 2.62a 2.55ab 2.47b 2.47b 0.03 0.003 
Gain: Feed, kg/kg 
   Day 0-7 0.58 0.56 0.52 0.53 0.02 NS 
   Day 7-14 0.58 0.60 0.58 0.60 0.02 NS 
   Day 15-21 0.57 0.58 0.59 0.55 0.02 NS 
   Day 22-28 0.60 0.55 0.56 0.52 0.02 NS 
   Day 29-35 0.41 0.41 0.43 0.43 0.01 NS 
   Day 36-42 0.42 0.43 0.43 0.43 0.01 NS 
   Day 43-49 0.43 0.46 0.43 0.44 0.02 NS 
   Day 50-56 0.35 0.36 0.35 0.38 0.02 NS 
   Day 57-63 0.37 0.41 0.40 0.36 0.02 NS 
   Day 63-70 0.35 0.36 0.39 0.38 0.01 NS 
   Day 71-77 0.31 0.35 0.31 0.35 0.02 NS 
   Day 0-42 0.51 0.50 0.50 0.49 0.01 NS 
   Day 43-77 0.35 0.36 0.39 0.38 0.01 NS 
Overall (d 0-77) 0.44 0.45 0.45 0.44 0.004 NS 
1Values are least-squares means (n=10 pens/treatment). Data were analyzed as a randomized complete 
block design. Differences between treatment means were determined using the Tukey-Kramer mean 
separation test with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10.  
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6 SEM, Standard error of means 
7NS, Not significant (P > 0.05) 
a, b, c Means without a common superscript within a row are significantly different. 
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 Table 10 Carcass characteristics for pigs fed diets containing graded levels of DON for 77 d1 
Item CONT2 DON13 DON34 DON55 SEM6 P-value 
pigs/treatment 31 37 37 39   
Live weight, kg 122.65 121.48 119.42 116.68 1.62  NS7 
Slaughter weight, kg 99.49 97.08 96.22 94.85 1.32 NS 
Backfat thickness, mm 16.54 15.68 15.93 16.20 0.62 NS 
Loin depth, mm 67.95 67.39 65.15 65.33 0.99 NS 
Yield, % 61.91 62.36 62.07 61.97 0.30 NS 
Dressing, % 81.40 80.00 80.56 81.29 1.07 NS 
1Values are least-squares means (n=10 pens/treatment). Data were analyzed as a randomized complete 
block design. Differences between treatment means were determined using the Tukey-Kramer mean 
separation test with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10. 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6SEM, Standard error of means 
7NS, Not significant (P > 0.05) 
 
 
4.3.2 Relationship between dietary DON intake and body weight gain 
The relationship between dietary DON intake and body weight gain was evaluated using a 
linear regression model as shown in Fig. 7. In general, there was a negative relationship between 
DON intake and ADG in the grower phase and over the entire growth performance study, however, 
there was only a weak relationship in the finisher phase. The relationship between DON intake 
and body weight gain of the treatment groups (DON1, DON3, and DON5) relative to CONT is 
presented in Fig. 6. The results indicated that an increase in DON intake reduced the rate of BW 
gain relative to the CONT pigs. Further, an increase in DON intake increased the magnitude of 
BW change relative to the CONT in a linear trend. The observation above was present throughout 












Figure 6 Regression analysis showing the relationship between deoxynivalenol (DON) intake and 
body weight change (%) relative to control (no DON) fed pigs during the grower phase d 0-42 (A), 
finisher phase d 42–77 (B), and overall d 0–77 (C). Each data point represents a pen (n=10 
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pens/treatment). Data expressed as the DON intake (mg/d) based on average daily feed intake and 
the bodyweight change of the DON treated groups relative to the control (CONT) group of pigs. 
The coefficient of determination (R2) are 0.14, 0.001, and 0.22 for figure A (grower phase), figure 







Figure 7 Regression analysis of the relationship between deoxynivalenol (DON) intake and average daily 
gain (ADG) in pigs fed DON-contaminated diets during the grower phase d 0-42 (A), finisher phase d 42-
77 (B), and overall d 0-77 (C). Each point on the graph represents an experimental pen (n=10 
pens/treatment). Data are expressed as the DON intake (mg/d) based on average daily feed intake and the 
bodyweight change of the DON treated groups relative to the control (CONT) group of pigs. The coefficient 






























































of determination (R2) of the regression curve is 0.26, 0.10, and 0.35 for figure A (grower phase), figure B 




4.3.3 Nitrogen balance 
Nitrogen-balance results are presented in Table 11. In the grower phase, the N-intake of 
pigs fed DON3 and DON5 diets was lower (P < 0.05) compared to pigs fed CONT and DON1 
diets. Digestibility of N was higher (P < 0.05) for CONT and DON3 pigs compared to DON1-fed 
pigs but not different from DON5 fed pigs and fecal N output was higher (P < 0.05) in DON1 fed 
pigs compared to all other treatments. Urinary N output was not affected (P > 0.05) by dietary 
treatments. Nitrogen retention and PD were reduced (P < 0.05) in pigs fed DON3 and DON5 
compared to CONT and DON1 fed pigs, which were not different. In the finisher phase, N intake 
was higher (P < 0.05) in DON1 fed pigs compared to CONT and DON3, but not different from 
DON5. Nitrogen digestibility was lower (P < 0.05) in all DON treatments (DON1, DON3, DON5) 
compared to CONT fed pigs resulting in increased fecal N output for all DON treatments.  Urinary 
N output was not affected (P < 0.05) by dietary treatment. Overall, nitrogen retention and PD were 
not affected by dietary treatment in the finisher period (P > 0.05). 
 
4.3.4 Liver and kidney metabolites  
Selected indicators of kidney and liver health and function are presented in Table 12 and 
Table 13 respectively for the grower and finisher phases of the study. Generally, no significant 
effects (P > 0.05) of dietary DON on the selected liver and kidney metabolites were observed. 
 
4.3.5 Concentration of DON in serum and urine 
 A linear regression model showed a significant positive relationship (P < 0.05) between 
dietary DON intake and DON concentration in serum (in both grower and finisher phases; Fig. 8)  
and recovery in urine (in both grower and finisher phases; Fig. 9). There were also no significant 




Table 11 Nitrogen balance results for pigs fed deoxynivalenol contaminated diets1 
 Dietary Treatment     
Items CONT2 DON13 DON34 DON55 SEM6 P-value 
Grower pigs (d 0 - 42) 
N7 intake, g/d 68.2a 66.9a 62.6b 58.6b 1.57 0.001 
ATTD8, of N, % 84.9a 79.9b 83.7a 82.7ab 0.92     0.001 
Urinary N output, g/d 21.6 21.6 21.5 20.6 1.50 NS9 
Fecal N output, g/d 10.3b 13.4a 10.2b 10.1b 0.47 0.001 
N retained, g/d 36.4a  31.9ab 30.9b 27.8b 1.75 0.001 
N retained, %     53.3 47.7 49.2 47.7 2.17 NS 
Protein deposition10,g/d 227.2a 199.9ab 193.2b 173.7b 10.94 0.001 
Finisher pigs (d 42-77) 
N7 intake, g/d 77.9b 83.7a 75.2b 80.4ab 1.41 0.001 
ATTD8, of N, % 91.2a 88.1b 87.6b 87.8b 0.52 0.001 
Urinary N output, g/d  35.7 32.5 31.5 34.5 1.86 NS 
Fecal N output, g/d 6.9b 9.9a 9.4a 9.8a 0.46 0.001 
N retained, g/d 35.4 41.3 34.2 36.0  2.17 NS 
N retained, % 45.4 49.3 45.0 44.9 2.52 NS 
Protein deposition, g/d 221.4 258.1 214.0 225.3 13.5 NS 
1Values are least-squares means (n=10 pens/treatment); DON, deoxynivalenol. Data were analyzed as a 
randomized complete block design. Differences between treatment means were determined using the 
Tukey-Kramer mean separation test with significance determined at P ≤ 0.05 and a trend towards 
significance at 0.05 < P < 0.10. 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6SEM, Standard error of means 
7N, nitrogen  
8ATTD, Apparent total tract digestibility 
9NS, Not significant (P > 0.05) 
10Protein deposition = N retained × 6.25  




Table 12 Grower phase (d 0 – 42) serum chemistry panel for liver and kidney metabolites analysis1 
Item Day CONT2 DON13 DON34 DON55 SEM6 
P-value 
Diet Day Diet × Day 
Sodium, mM 0 144.6 144.5 142.9 142.8 0.77    
 14 145.8 145.9 145.4 142.9 0.77 NS7 0.001 0.015 
 42 145.5 146.1 145.2 147.5 0.77    
Potassium, mM 0 6.52 6.33 6.29 6.29 0.44    
 14 5.96 6.21 5.46 5.46 0.44 NS 0.008 NS 
 42 5.60 5.24 5.60 5.60 0.44    
Chloride, mM 0 96.6 96.4 96.0 95.3 0.63    
 14 95.8 97.2 96.6 96.2 0.63 NS NS NS 
 42 96.3 96.5 96.3 97.3 0.63    
Bicarbonate, mM 0 19.4 21.0 20.6 20.8 0.87    
 14 18.6 21.1 21.4 20.8 0.87 NS 0.001 NS 
 42 26.3 25.7 25.7 27.7 0.87    
Anion Gap, mM 0 35.4 33.4 32.6 33.6 1.23    
 14 37.5 33.8 32.8 32.1 1.23 NS 0.001 NS 
 42 29.1 29.8 28.9 28.3 1.23    
Calcium, mM 0 2.88 2.85 2.78 2.82 0.05    
 14 2.95 3.04 2.88 2.78 0.05 NS 0.049 NS 
 42 2.87 2.83 2.83 2.88 0.05    
Phosphorus, mM 0 3.32 3.25 3.19 3.26 0.08    
 14 3.38 3.19 3.10 3.13 0.08 NS 0.010 NS 
 42 3.12 2.98 3.11 3.18 0.08    
Magnesium, mM 0 0.84 0.83 0.77 0.78 0.03    
 14 0.87 0.85 0.81 0.80 0.03 NS 0.040 NS 
 42 0.86 0.86 0.86 0.87 0.03    
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Table 12 (continued) Grower phase (d 0 – 42) serum chemistry panel for liver and kidney metabolites analysis1 
Urea, mM 0 4.48 4.61 3.84 3.79 0.26    
 14 3.72 3.84 3.69 3.72 0.26 NS 0.001 NS 
 42 4.99 5.43 4.72 4.80 0.26    
Creatinine, mM 0 69.0 73.6 68.6 71.9 3.55    
 14 82.5 85.7 82.6 86.5 3.55 NS 0.001 NS 
 42 99.6 108.3 95.3 100.7 3.55    
Glucose, mM 0 6.57 6.23 6.41 6.36 0.00    
 14 6.92 6.14 5.97 5.97 0.00 NS NS NS 
 42 5.82 6.10 5.85 6.20 0.00    
Total Bilirubin, mM 0 0.32 0.37 0.45 0.37 0.62    
 14 0.29 0.38 0.22 0.43 0.62 NS NS NS 
 42 0.34 0.35 0.22 0.36 0.62    
Direct Bilirubin, mM 0 0.27 0.25 0.28 0.21 0.03    
 14 0.15 0.23 0.15 0.12 0.03 NS 0.001 NS 
 42 0.20 0.16 0.11 0.18 0.03    
Indirect Bilirubin, mM 0 0.05 0.12 0.17 0.16 0.05    
 14 0.14 0.15 0.07 0.31 0.05 0.042 NS NS 
 42 0.14 0.22 0.11 0.18 0.05    
GGT8, mM 0 32.4 30.1 32.6 35.9 2.78    
 14 34.2 32.6 34.0 34.8 2.78 NS NS NS 
 42 34.2 33.7 33.9 38.4 2.78    
GLDH9, mM 0 1.50 1.49 1.70 1.29 0.18    
 14 1.60 1.49 1.50 1.29 0.18 NS 0.007 NS 
 42 1.33 1.10 0.90 1.11 0.18    
AST10, mM 0 26.0 22.1 22.4 23.9 4.33    
 14 22.2 18.4 19.2 23.1 4.33 NS NS NS 
 42 33.9 15.8 16.7 15.7 4.33    
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Table 12 (continued) Grower phase (d 0 – 42) serum chemistry panel for liver and kidney metabolites analysis1 
CK11, mM 0 2192 1290 1159 1445 1229    
 14 4144 2723 2387 2360 1229 NS 0.001 NS 
 42 8052 3622 8384 4200 1229    
Total Protein, mM 0 53.9 54.3 53.6 55.1 1.15    
 14 58.7 59.5 56.6 55.6 1.15 NS 0.001 0.049 
 42 62.4 61.8 58.7 62.8 1.15    
Albumin, mM 0 13.1 13.6 13.6 15.4 0.97    
 14 15.9 15.7 15.7 16.7 0.97 NS 0.001 NS 
 42 15.3 14.2 12.4 16.0 0.97    
Globulin, mM 0 13.1 13.6 13.6 15.4 0.97    
 14 15.9 15.7 15.7 16.7 0.97 NS 0.001 NS 
 42 15.3 14.2 12.4 16.0 0.97    
Albumin:Globulin, mM 0 3.23 3.17 3.07 3.75 0.22    
 14 2.82 2.89 2.66 2.45 0.22 NS 0.001 NS 
 42 3.23 3.45 3.75 3.02 0.22    
1Values are least-squares means (n=10/treatment); DON, deoxynivalenol. The data was analyzed above was analyzed as a repeated 
measure with ‘day’ as a repeated variable. Differences between treatment means were determined using the Tukey-Kramer mean separation test 
with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10. 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6 SEM, Standard error of means. 
7NS, Not significant (P > 0.05) 
8GGT, Gamma-glutamyltransferase 
9GLDH, Glutamate dehydrogenase 
10AST, Aspartate aminotransferase 
11CK, Creatine kinase  
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Table 13 Finisher phase (d 42 – 84) serum chemistry panel for liver and kidney metabolites analysis1. 
Item Day CONT2 DON13 DON34 DON55 SEM6 
P-value 
Diet Day Diet × Day 
Sodium, mM 42 147.5 148.4 149.5 148.6 2.15    
 56 143.9 145.0 144.3 144.9 2.15 NS7 0.050 NS 
 84 144.6 149.2 147.9 149.1 2.24    
Potassium, mM 42 5.80 5.46 5.66 5.16 0.19    
 56 5.25 5.54 5.35 5.32 0.19 NS 0.058 NS 
 84 5.13 5.22 5.44 5.07 0.20    
Chloride, mM 42 98.1 97.8 99.2 98.4 1.47    
 56 95.0 95.9 94.9 95.4 1.47 NS 0.005 NS 
 84 96.5 99.4 99.3 100.4 1.55    
Bicarbonate, mM 42 23.1 24.6 24.0 24.8 0.83    
 56 22.5 22.9 22.5 23.2 0.83 NS 0.001 NS 
 84 26.4 27.6 28.5 28.7 0.87    
Anion Gap, mM 42 32.3 31.3 32.0 30.6 1.24    
 56 31.7 31.4 32.2 31.9 1.22 NS 0.001 NS 
 84 27.1 27.0 25.8 25.1 1.27    
Calcium, mM 42 2.88 2.85 2.86 2.80 0.08    
 56 2.73 2.78 2.75 2.65 0.08 NS NS NS 
 84 2.60 2.81 2.81 2.98 0.08    
Phosphorus, mM 42 3.15 3.06 3.07 3.06 0.08    
 56 2.95 2.93 2.84 2.82 0.08 0.022 0.001 0.25 
 84 2.63 2.71 2.43 2.28 0.08    
          




Table 13 (continued) Finisher phase (d 42 – 84) serum chemistry panel for liver and kidney metabolites analysis1. 
Magnesium, mM 42 0.80 0.78 0.83 0.78 0.03    
 56 0.81 0.77 0.73 0.75 0.03 NS 0.001 NS 
 84 0.87 0.91 0.87 0.88 0.03    
Urea, mM 42 5.96 5.80 6.12 6.10 0.33    
 56 5.56 5.65 5.37 5.49 0.33 NS 0.020 NS 
 84 5.81 6.05 6.03 5.64 0.34    
Creatinine, mM 42 91.3 96.2 95.1 96.4 5.09    
 56 106.8 106.7 108.1 108.0 5.09 NS 0.001 NS 
 84 126.5 135.9 133.3 133.3 5.27    
Glucose, mM 42 5.83 5.69 6.00 5.56 0.24    
 56 6.19 5.25 5.43 5.26 0.24 NS 0.007 NS 
 84 5.34 5.25 5.49 4.96 0.26    
Total Bilirubin, mM 42 0.23 0.07 0.18 0.22 0.12    
 56 0.23 0.17 0.40 0.10 0.12 NS NS NS 
 84 0.37 0.41 0.23 0.35 0.12    
Direct Bilirubin, mM 42 0.15 0.10 0.10 0.19 0.04    
 56 0.12 0.13 0.07 0.06 0.04 NS 0.003 NS 
 84 0.18 0.26 0.16 0.19 0.04    
Indirect Bilirubin, mM 42 0.08 0.00 0.08 0.03 0.11    
 56 0.11 0.04 0.33 0.04 0.11 NS NS NS 
 84 0.19 0.15 0.06 0.16 0.12    
GGT8, mM 42 34.2 33.6 29.1 32.9 2.73    
 56 32.1 33.1 29.9 32.8 2.73 NS 0.040 NS 




Table 13 (continued) Finisher phase (d 42 – 84) serum chemistry panel for liver and kidney metabolites analysis1. 
GLDH9, mM 42 34.15 33.69 29.10 32.86 2.73    
 56 32.05 33.10 29.90 32.76 2.73 NS 0.040 NS 
 84 35.49 36.60 31.57 36.51 2.83    
AST10, mM 42 24.87 17.42 19.40 19.83 3.97    
 56 27.07 18.44 26.40 23.53 3.20 NS NS NS 
 84 15.81 20.84 17.97 16.87 4.09    
CK11, mM 42 3589 3593 3706 3619 914    
 56 4110 2803 4151 3144 914 NS 0.040 NS 
 84 2409 2224 2808 2280 958    
Total Protein, mM 42 63.29 62.71 63.40 64.18 1.76    
 56 61.59 60.83 61.50 62.38 1.76 NS NS NS 
 84 61.46 63.93 62.11 65.94 1.86    
Albumin, mM 42 48.96 48.27 47.60 47.90 1.15    
 56 47.66 46.46 46.50 46.70 1.14 NS NS NS 
 84 47.48 48.66 47.30 47.85 1.19    
Globulin, mM 42 14.37 14.40 15.80 16.25 0.89    
 56 13.97 14.33 15.00 15.65 0.89 NS NS NS 
 84 13.97 15.23 14.82 17.90 0.93    
Albumin:Globulin, mM 42 14.37 14.40 15.80 16.25 0.89    
 56 13.97 14.33 15.00 15.65 0.87 NS NS NS 
 84 13.97 15.23 14.82 17.90 0.91    
1Values are least-squares means (n=10/treatment); DON, deoxynivalenol. The data was analyzed above was analyzed as a repeated 
measure with ‘day’ as a repeated variable. Differences between treatment means were determined using the Tukey-Kramer mean separation test 
with significance determined at P ≤ 0.05 and a trend towards significance at 0.05 < P < 0.10. 
2CONT, 0 ppm DON Control diet 
3DON1, 1 ppm DON diet 
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4DON3, 3 ppm DON diet 
5DON5, 5 ppm DON diet 
6 SEM, Standard error of means. 
7NS, Not significant (P > 0.05) 
8GGT, Gamma-glutamyltransferase 
9GLDH, Glutamate dehydrogenase 
10AST, Aspartate aminotransferase 

















Figure 8 Regression analysis of the relationship between deoxynivalenol (DON) intake and DON 
output in serum (n=10 pigs/treatment). The serum samples were collected during the nitrogen 
balance period of experiment 3-4h after a single meal and analyzed for DON content. The figure 
A represents the grower phase and figure B represents the finisher phase of the experimental 
animals. Data are expressed as the DON intake (mg/meal) and the serum DON output (ng/mL) 
and the coefficient of determination (R2) of the regression curve is 0.87 and 0.88 for figure A 
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Figure 9 Regression analysis of the relationship between deoxynivalenol (DON) intake and DON 
output in urine (n=10 pigs/treatment). The urine samples were collected during the nitrogen 
balance period of the experiment over 24-h and analyzed for DON content. The figure A represents 
the grower phase and figure B represents the finisher phase of the experimental animals. Data are 
expressed as the DON intake per day (mg/d) and the urine DON output (mg/d) and the coefficient 
of determination (R2) of the regression curve is 0.87 and 0.78 for figure A (grower phase) and 























































Figure 10 Deoxynivalenol (DON) recovery in urine expressed as a percentage of DON intake per pig 
per d for both the grower and finisher phases fed diets containing 1, 3, or 5 ppm DON (DON1, DON3, 
DON5, respectively. Bars represent urinary DON recovery shown as least square means ± SEM 
(n=10 pigs/treatment). Differences between treatment means were determined using the Tukey-Kramer 












































4.3.6 Immune response measurement 
Immune response data presented in Fig. 11 shows that there was a day effect (P < 0.05) on 
IgG titers in response to the Leptospirosis vaccine, however, there were no effects of diet or diet x 




Figure 11 Serum IgG titers (mg/dL) in response to Leptospira spp. for grower phase (A) sampled 
on day 0, 14, and 42 and finisher phase (B) samples taken on day 42, 56, and 84 of the experiment 
representing d 0, 14, and 42 during the finisher phase respectively for pigs fed DON-contaminated 














































DON effect: P > 0.05
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Bars represent least-square means ± SEM (n=10 pigs/treatment). Differences between treatment 
means were determined using the Tukey-Kramer mean separation test with significance determined at P ≤ 






5.0 GENERAL DISCUSSION  
Mycotoxin contamination in livestock diets is considered a global challenge. More so, the 
effect of DON contamination of cereal grains, which is increasing, has a significant impact on 
swine production. In general, pigs are the most affected livestock species by DON contamination 
as evidenced by physiological and growth performance responses reported in pigs fed DON-
contaminated diets (Serviento et al., 2018). The reported effects of feeding pigs DON-
contaminated diets include poor growth (Serviento et al., 2018; Girardet et al., 2011), impaired 
health (Pestka, 2010; Chaytor et al., 2011), and poor nutrient utilization (Santurio, 2000). These 
effects have been reported in pigs of all ages, however, there is some evidence that younger pigs 
may be more susceptible, even at lower doses (Alizadeh et al., 2015; Dersjant-Li et al., 2003; Chen 
et al., 2008; Savard et al., 2015). The majority of previous studies have focused on shorter exposure 
times (Accensi et al., 2006; Alizadeh et al., 2015; Dänicke et al., 2017) and assessed effects in 
younger pigs, therefore, this thesis examined the effects of feeding graded levels of DON to both 
grower-finisher (35 – 120 kg) and finisher (75 – 120 kg) pigs on growth performance, nutrient 
utilization, carcass characteristics, and overall health status during a long-term (42-d and 77-d, 
respectively) period. Although the CFIA has set the maximum allowable limit for DON in 
complete swine diets at 1 ppm, there is evidence indicating that pigs may have the potential to 
tolerate higher DON levels (Rotter et al., 1995; House et al., 2002; Dänicke et al., 2017; Serviento 
et al., 2018). Besides, some studies have suggested that pigs may be able to adapt to the effects of 
DON-contaminated diets during an extended exposure period (Rotter et al., 1994; Rotter et al., 
1996; Serviento et al., 2018). The potential for recovery and adaptation may offer producers the 
opportunity for increased use of feedstuffs contaminated with DON in swine diets, provided 
economic impact is favorable. Therefore, the objective of this thesis was to assess the effects of 
feeding graded levels of DON on growth performance, nutrient utilization, health, and carcass 
characteristics of grower-finisher pigs. We also aimed to determine the difference in performance 
response between younger (grower pigs) and older pigs (finisher pigs) to DON contamination. 
Finally, given the difficulties with determining mycotoxin content in feeds and feedstuffs, we 
aimed to evaluate the effect of DON content in biological samples, such as urine and blood, and 




5.1 DON concentration in the experimental diets: analyzed vs. calculated 
The experimental diets presented in this thesis were formulated to target dietary DON 
levels at 0, 1, 3, and 5 ppm. For the most part, the formulated and analyzed levels of the DON in 
the complete diets were similar. The major exception to this was the variation observed in DON 
level for the control diets used in the N-balance determination, which was analyzed to be 1.01 ppm 
for the grower period in experiment 1, and 1.56 ppm in the finisher period in both studies. This 
highlights the difficulty in analyzing actual DON content in feedstuffs and knowledge of final 
DON concentration in complete feeds, as the same ingredients were used for both the diets used 
in manufacturing the diets for growth performance and N-balance. Kong et al. (2016) reported 
DON levels ranging from 2.94 to 5.07 mg/kg in complete diets even though the same amount of 
DON-contaminated barley was used in the diet formulation. Similarly, Patience et al. (2014) 
reported that when two diets were formulated to have the same level of DON using the same 
amounts of DON-contaminated corn, the analyzed DON levels in the two diets were significantly 
different (0.25 mg/kg vs. 4.6 mg/kg). These studies further demonstrate the inconsistency in 
estimating DON contamination levels in complete diets.  
Some reports suggest that the inaccuracies in the estimation of DON in complete diets 
could be due to the mechanisms by which Fusarium infects grain and proliferates in spots or 
localized portions of the grain batch during storage, leading to uneven distribution of Fusarium 
growth in samples (Swamy et al., 2002; Kong et al., 2015;  2016). Other factors that may influence 
the overall accuracy of testing for DON include sampling methods, sample size, sample 
preparation, including particle size, and methods of analyzing samples (Freese et al., 2000). For 
example, one study reports that when testing samples for DON in the whole grain, there is a greater 
variation (SD = 76) compared to samples tested after grinding (SD = 56; Champeil et al., 2004). 
This observation was confirmed by Sanders et al. (2013) who recorded very high levels of DON 
in wheat dust compared with whole wheat grains. The sample size also influences the accuracy of 
results, with a range of about 100 – 200 g and sampling from multiple locations being 
recommended as ideal (Freese et al., 2000). Results from our mycotoxin analysis of the 
experimental diets showed that other potentially harmful mycotoxins such as ZEA, FUM, and 
ergot alkaloids were significantly below harmful levels (CFIA, 2017), as such all effects and 
responses recorded will be assumed to be attributed solely to DON contamination. This is not to 
disregard the fact that mycotoxin co-contamination is widely researched and reported in the 
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literature, especially in grains naturally contaminated with Fusarium mycotoxins, since co-
contamination can alter and or increase the severity of the response (D’Mello et al., 1999; 
Bracarense et al., 2012; Schatzmayr and Streit, 2013; Pinotti et al., 2016; Alassane-Kpembi et al., 
2017). Results from the mycotoxin analysis in the experimental diets also suggest that swine diets 
in current commercial use may contain DON and potentially other mycotoxins. 
 
5.2 Growth performance of pigs fed DON-contaminated diets  
There is evidence that feeding DON-contaminated diets to pigs affects performance 
(Serviento et al., 2018), including average daily gain, feed intake, and feed efficiency. Factors that 
compromise feed intake will directly reduce nutrient intake, hence growth will be impaired 
(Pastorelli et al., 2012; Kong et al., 2016). Results presented in this thesis agrees with the CFIA 
recommended levels of 1 ppm in complete diets for pigs such that consistently and throughout 
both Expt. 1 and 2, there were no significant differences between pigs fed the CONT diets and 
pigs fed the DON1 diets. In the finisher experiment (Expt. 1), during the first week of the study, 
we observed a 34 % reduction in ADFI of the DON5-fed pigs compared to the CONT pigs, whereas 
pigs fed DON3 treatment showed less of an effect from DON with a 14% reduction in ADFI and 
pigs fed DON1 diets showed no effect due to DON. The reduction in respective ADFI across the 
treatments subsequently resulted in a 53% drop in ADG of the DON5-fed pigs with DON3-fed 
pigs showing a lower impact with a 27% drop in ADG. This observation is consistent with a 
previous report by Serviento et al. (2018) where pigs were fed with DON-contaminated diets over 
two periods with a DON-free treatment between the 2 periods and showed a 30 % reduction in 
ADFI and a subsequent 54 % reduction in ADG compared to the pigs fed no DON diets during the 
same period (d 0-7) of exposure in period 1. We further observed that the negative effects due to 
continuous exposure to DON-contaminated diets on ADFI and ADG were reduced over time 
where DON1 and DON3 treatment groups were statistically not different from the control group 
(CONT), as indicated by the lack of effect of dietary treatment on ADG and ADFI after 4 weeks 
of exposure. Overall, the ADG for DON3 and DON5 was lower when compared to DON1 and 
CONT. ADFI for DON5 pigs was lower than all other treatments and there was no effect of feeding 
DON on G:F. The observed results on ADG suggest that the initial exposure period (d 0-7) to DON 
elicited the greatest impact on ADG, followed by a steady decline in the severity of the effects of 
DON until there was no effect on performance, similar to previous reports (Li et al., 2011; Van Le 
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Thanh et al., 2015). This result provides evidence that pigs fed 5 ppm DON may adapt to the DON 
exposure, with recovery in performance after an initial negative response. The DON3 and DON1 
treatments showed less of an effect and quicker adaptation, where DON1 pigs were largely 
unaffected by DON intake and responded similarly to the CONT pigs. Studies have suggested that 
nutrient, utilization, and protein synthesis may be compromised by DON intake in pigs (Chaytor 
et al., 2011), but no impact on feed efficiency was observed except during the first week in the 
DON5-fed pigs. This may suggest that in finisher pigs, the effects of DON intake on growth 
performance may be largely due to the effects of DON on feed intake. These observations agree 
with a meta-analysis by Pastorelli et al. (2012), which reported that 80% of the reduction in ADG 
observed with mycotoxin contamination in pigs could be related to impaired feed intake.  
Growth performance results from Expt. 2 showed that ADFI was reduced by 11 – 12% in 
the DON5 and DON3 fed pigs compared to the CONT group with no effect on DON1 fed pigs 
during the d 0–7. The effect on ADFI resulted in a 22% and 17% drop in ADG for the DON3 and 
DON5 fed pigs, respectively. This observation confirms previous reports in terms of the initial 
response and effects of growing pigs fed DON-contaminated diets (Li et al., 2011; Van Le Thanh 
et al., 2015). Generally during the grower phase (d 0-42), on a week to week basis, there was no 
significant variation between treatments for ADFI except during d 0-7, and d 22-28. The ADG was 
therefore not affected beyond d 7 during the same phase (d 0–42), as was reported previously 
(House et al., 2002; Dänicke et al., 2004). During the finisher phase (d 43–77), there was a 
significant reduction (15%) in ADFI for DON5-fed pigs, whiles an 8% reduction was observed 
during d 43–49, and a 6% reduction in DON3 pigs from d 50 – 56. These results are unexpected 
as pigs had already been exposed to DON for an extended period and therefore the results may be 
attributed to the switch from the grower phase diet to the finisher phase diet. Again, individual 
animal variability or dose of DON contamination during that period may account for the observed 
response as previously argued (Nguyen-Ba et al., 2020). The reduced feed intake during the early 
periods of the finisher phase resulted in a 15% reduction in ADG for pig groups fed the DON5 
treatment during the d 43–49 period only. There was, however, no further effect of treatment on 
ADG during the rest of the finisher phase (d 50–77). Overall, there was no effect on G:F throughout 
the entire experiment for both growth phases. The ADFI was more affected during the finisher 
phase (d 43-77), with no effect during the grower phase, whereas ADG was affected only during 
the grower phase (d 0-42). The difference in BW gained at the end of the grower phase was 3.6 kg 
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representing a 4% reduction in BW gain for DON5 pigs when compared to the pigs on the clean 
diets, while DON3 pigs were 3.9% lighter than the control group. At the end of the study, the 
overall reduction in BW gain in the DON3 and DON groups was 3.1% and 3.9% respectively but 
had no impact on carcass traits (House et al., 2002). 
In the grower-finisher experiment (Expt. 2), it was evident that the initial exposure of 
grower pigs to the DON5 diets showed a less drastic effect compared to the finisher pigs, with a 
10% vs 34% drop in ADFI, respectively, during the first 7 d. This trend was also observed during 
the same period for ADG, with grower pigs showing a 17% drop in ADG compared to a 52% 
reduction in ADG observed in finisher pigs. For DON3 pigs, on the other hand, ADFI and ADG 
were reduced by 14% and 27% during the first 7 d of exposure while in the grower-finisher study, 
there was a reduction of 12% and 22% for ADFI and ADG compared to the control group. 
Throughout the 2 studies, finisher pigs showed a gradual reduction in adverse effects whereas 
grower pigs seem to recover relatively quickly after the initial drastic reduction by DON on both 
feed intake and daily gain. There was a clear indication that the response for the grower pigs is not 
the same as was observed for the finisher pigs (Expt. 1) and by others (Flannery et al., 2011; 
Nguyen-Ba et al., 2020). However, at the end of the grower phase (d 0-42) for experiment 2, there 
was no effect of DON on ADFI but ADG had been reduced by only about 7% for pigs fed the 
highest DON (DON5) compared to pigs on clean diets (CONT). Comparing results in the two 
studies, finisher pigs showed more severe effects due to DON intake compared to grower pigs, 
suggesting that grower pigs may be less susceptible to DON exposure in diets.  
It is thought that pigs have the potential to adapt to DON, and therefore a week by week 
regression analysis was used to establish the relationship between actual DON intake and the 
relative change in BW and ADG in both Expt. 1 and 2. In Expt. 1 (finisher study), pigs fed DON-
contaminated diets show a consistent depression in BW gain and ADG, which show a gradual 
recovery over time. On the contrary, during Expt. 2 (grower-finisher), we observed a less drastic 
initial response and a greater degree of variability in response to DON intake. The longer exposure 
to DON during Expt. 2 (grower-finisher), resulted in an overall drop in ADFI and ADG of 5.7 % 
and 5.2 %, respectively, whereas in Expt. 1 (finisher) ADFI and ADG were reduced by 13% and 
16% respectively when DON5 was compared to CONT. Also, this variability may due to variations 
of individual animal responses which may suggest that recovery from DON contamination may be 
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based on individual animal traits such as size and stage of development as well as resilience to 
DON (Nguyen-Ba et al., 2020).  
In both Expt.1 and 2, DON1 fed pigs responded similarly to the CONT fed pigs, as such 
there were no significant differences observed for all performance parameters measured – BW 
gain, ADG, ADFI, and G:F. Again, comparing DON5 to the CONT group of pigs, there was only 
a 4% drop in final BW for Expt. 2 compared to the 7% for Expt. 1. The final BW of pigs on the 
DON3 diets were not different from DON5. When the final BW of DON3-fed pigs was compared 
for both experiments, there was only a reduction of 2% for Expt. 1 compared to 3% for Expt. 2.  
This effect of DON on final BW for DON5, when compared to CONT, was affected by the initial 
response (d 0-7) in ADG which was a 53% and 17% reduction for the finisher and grower pigs 
respectively,  including a 34% and 10%  lower ADFI for finisher and grower pigs respectively. 
Results from this study, therefore, suggest that younger animals may be less susceptible to DON 
intake and might take less time to recover as compared to older pigs (Serviento et al., 2018; Van 
Le Thanh et al., 2015; Reddy et al., 2018). The effect of DON on ADFI may be due to various 
mechanisms including palatability attributed to the growth of mold in the diets (Higgins and 
Brinkhaus, 1999; Serviento et al., 2018). Serviento et al. (2018) and Goyarts and Dänicke (2005), 
further reported that DON-fed to pigs had altered feeding behavior i.e., feeding frequency was 
reduced) implying that the pigs may not have sufficient feed intake to meet their daily nutrient 
requirements, reducing performance. 
In effect practical approaches to the use of DON-contaminated ingredients in swine diets 
might be to evaluate the feasibility of feeding smaller frequent meals, however, this may impose 
challenges in the commercial setting. Nguyen-Ba et al. (2020) further suggested that there may be 
the potential for exploitation of breeding programs for the development of swine with low 
susceptibility to DON and other mycotoxins citing that, the phenotypic measurements of this trait 
are highly heritable. Also, the nutrient density of diets could be adjusted such that for the same 
amount of energy intake, there is more than the required amino acids and other nutrients as 
suggested by the NRC (2012). This may afford pigs fed high DON diets to have adequate nutrient 
intake even at a reduced feed intake such that reduction in BW gain will be minimized. As shown 
previously, pigs have the potential to recover from the anorexic effect of DON when subsequent 
or continuous exposures are introduced (Serviento et al., 2018). Strategies for dietary adjustment 
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of nutrients will have to consider this observation to meet targeted growth levels when feed intake 
is reduced. 
 
5.3 Effect of DON on nutrient utilization and carcass characteristics 
A nitrogen (N) balance experiment measures N retention with the assumption that the 
majority of this retention is as lean tissue gain (i.e., protein deposition) in growing animals (Wu, 
2018). Nitrogen intake is important for lean gain and therefore, factors that affect N intake directly 
or N utilization affect protein deposition. There is evidence that suggests that DON intake might 
impact protein deposition in pigs (Swamy et al., 2002; Arthur and Herd, 2005). In mice, protein 
synthesis has been reported to be inhibited by DON intake (Azcona-Olivera et al.,1995). While we 
attempted to determine the impact of DON intake on N retention in the present studies, the lack of 
a true control diet due to the high levels of DON analyzed in the CONT diets, makes interpretation 
of the results difficult. In effect, the CONT group showed a more drastic response because DON 
levels in their diets during the growth performance were significantly lower compared to N-
balance diets. Exposing pigs to DON at any stage in their growth has been shown to significantly 
affect performance within the first week (d 0-7) of the exposure by reducing voluntary feed intake 
(Serviento et al., 2018). However, when the issue of voluntary feed intake is eliminated by feeding 
pigs according to their body weight, as in an N-balance study, there is still an impact on the 
performance of pigs, suggesting that other factors, such as nutrient utilization, may be at play. 
Other factors that could be responsible include other physiological differences and potential effects 
on the microbiome of the pigs which together work for the efficient growth of the pig. These 
factors, however, were not addressed in this study. 
During Expt. 1 the digestibility of N was observed to be increased with the intake of the 
DON-contaminated diets (DON1, DON3, and DON5) compared to the control group (CONT) by 
as much as 8 – 10% which is in agreement with Goyarts and Dänicke, (2005) where DON-
contaminated diets led to a significant increase in protein digestibility up to 6%. This was most 
likely because the CONT group were being exposed to greater levels of DON compared to what 
they were exposed to during the performance period. Dänicke et al. (2004) and Kong et al. (2016) 
reported that there were no effects of DON on N digestibility, which suggests that the response to 
DON in diets of finishing pigs can be variable depending on factors such as the individual animal 
variability, and the duration of exposure. In our current study, the CONT-fed pigs which were fed 
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diets containing 0.11 ppm DON during the growth performance period were effectively exposed 
to diets containing 1.56 ppm DON during the nitrogen balance period, which when inferring from 
the performance results, drastically had a negative effect on the pigs during the balance study. This 
is evident in the overall N-retention of the CONT group, which was not different from the high 
DON diets (DON3 and DON5). In principle and based on the results, the pigs fed the DON1 diets 
represent more of a control group which was quite evident in the overall high retention of N (65%) 
compared to the DON3, DON5 and, CONT pigs. The CONT group, however, can be argued to 
represent the effect of DON on nutrient utilization when DON is initially exposed to growing pigs. 
Though digestibility was low, there was also a significant amount of N wasted through the output 
of N in both urine and feces. Though there is no carcass data to support the overall translation of 
this result into carcass traits, the lack of effect of DON feed efficiency (G:F) during the 
performance period suggests that the initial exposure of pigs to DON reduces ADFI and ADG, and 
overall BW, however, as these growing pigs continue to feed on this same DON-contaminated 
diet, there is some recovery (ADG and ADFI) leading to an overall reduced effect. It is possible 
that the recovery time is insufficient to recover BW. The overall results, therefore, suggest that 
DON may have detrimental effects on nutrient utilization. 
During the growth phase of Expt. 2, CONT-fed pigs showed a significantly higher PD of 
227 g/d compared to pigs fed DON3 and DON5 diets (193 and 174 g/d, respectively) but was not 
different from DON1 pigs (200 g/d). Though DON1 showed significantly lower digestibility of N 
compared to CONT and CONT was not different from both DON3 and DON5 pigs. During the 
finisher phase, on the other hand, CONT treated pigs had a higher digestibility of N compared to 
all other treatments  (DON1, DON3, and DON5), however, there was no difference in final protein 
retention hence PD, which is supported by the growth performance data where G:F was not 
affected by the treatment of DON-contaminated diets for the overall exposure period. This agrees 
with Van Le Thanh et al. (2015) when diets containing 4.6 ppm DON were fed to 6 kg piglets for 
14 days and earlier results from House et al. (1986). The results from Expt. 2 suggests that, though 
in the short-term there could be depressed nutrient utilization as seen in the grower phase, extended 
exposure to DON affords growing pigs the opportunity to recover from any adverse effects of 
DON on nutrient use. Further, we observed that in the growth performance experiments, when the 
feed efficiency of pigs fed DON-contaminated diets was compared to pigs on control diets, there 
was no significant effect of DON, suggesting that the pigs were able to efficiently utilize nutrients 
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for growth. This observation is supported by the measured blood urea nitrogen data, which was 
not affected by dietary treatment and not different over time, and there was no treatment by day 
interaction, suggesting that the efficiency of uptake and utilization of N was not affected. In a study 
by Van Le Thanh et al. (2015), there was no impact of feeding DON to pigs on their N retention 
as was similar to results observed in the finisher phase of Expt. 2. On the contrary, the significant 
adverse effects of DON on N retention during experiment 1 may be due to the short exposure 
period (42 days) and specifically to the finisher experiment, may arise from the excessively high 
differences in DON levels between the diets used in the performance period (0.11 ppm) vs. diet 
used in the N-balance period (1.56 ppm). The gradual recovery rate of pigs from the drastic 
reduction in ADFI, which leads to a drop in ADG, versus the sustained negative effect on ADFI 
and the potential for DON to limit feed efficiency may have been rapid enough such that the 
negative effects of DON are managed or reduced as the pigs grow to adapt to the contaminated 
feed. Overall, the poor growth performance exhibited by pigs fed DON-contaminated diets can be 
attributed mainly to the limited feed intake rather than impaired feed utilization, especially at 
relatively low concentrations of 1 to 5 ppm used in this thesis as was also reported by Pastorelli et 
al. (2012). 
When CONT, DON3, and DON5 diets were fed to pigs in Expt. 1, it was apparent that the 
DON1-fed pigs responded as a control group and showed the higher PD compared to all other 
treatments but specifically was 36, 42, and 29% higher than CONT, DON3, and DON5-fed pigs, 
respectively. Interestingly, when there was no DON contamination in the diets of the CONT-fed 
pigs during the grower phase of Expt. 2, CONT-fed pigs showed only a 15 – 24% higher PD 
compared to DON3 and DON5 pigs, which is proportionally lower than the PD compared to Expt. 
1. Overall, however, when the finishing pigs in Expt. 2 were fed DON-contaminated diets there 
was no significant effect of the treatment suggesting a level of recovery and adaptation by the end 
of the Expt. 2. This further supports the results from the growth performance data, suggesting that 
younger pigs are less susceptible to DON-contaminated diets up to 5 ppm compared to older 
finisher pigs, and the continuous feeding of DON-contaminated diets may alleviate the overall 
negative effects of nutrient utilization. In the current study, the N-balance was carried out at the 
end of the exposure periods of the studies, which are after any potential adaptation, hence a lack 
of response may have been due to timing and not just the effect of DON. However, as indicated 
earlier the unexpectedly high DON content of the CONT diets used in Expt. 1 and the finisher 
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phase of Expt. 2 revealed the potential response to DON had the nitrogen balance been carried out 
by the end of the first week of exposure. The results are also supported by the response observed 
in the lack of effects of DON on feed efficiency (G:F) and urea levels measured in serum samples. 
Similar to reports by Bergsjø et al. (1993), House et al. (2002), and Serviento et al. (2018), our 
results showed that there was no impact of feeding DON-contaminated diets on carcass traits, 
suggesting that feed intake and nutrient utilization had largely recovered, despite a lack of recovery 
in body weight. 
 
5.4 DON effect on health and blood metabolites 
Liver and kidney metabolite analyses are key in identifying changes in the metabolism and 
health status of pigs following a period of ingestion of any toxin (Renner et al., 2017). Since DON 
is reported to be metabolized mainly in the intestine, liver, and kidney (Schwartz-Zimmermann et 
al., 2015), we evaluated kidney and liver metabolite changes in DON-fed pigs over time and 
observed no significant changes overall compared to pigs fed a control diet. The effects of DON 
contamination, or the lack of it thereof, were consistent with results from Rotter et al. (1995), 
Accensi et al. (2006), and Sayyari et al. (2018). Rotter et al. (1995) in a 42-d study, fed diets up to 
4 mg/kg DON and reported that DON reduced the synthesis of protein in the liver, however, the 
pigs recovered to normal feed intake. Similarly, weanling pigs fed graded DON levels (0, 280, 
560, or 840 µg/kg) show no effect of DON intake on hematological, biochemical changes in the 
blood  (Accensi et al., 2006). Increasing dietary DON levels had no effects on selected liver and 
kidney metabolites, some blood proteins, glucose, and electrolytes. Blood urea measurements, 
which are important to understand renal function, protein utilization, and efficiency (Kong et al., 
2015), were not affected by the increasing levels of DON in the experimental diets. A study by 
Accensi et al. (2006) observed similar results, though their study used piglets fed up to 840 µg/kg 
DON in contaminated diets over a 28-d. Further, Chaytor et al. (2011) also saw no effect of DON 
when it was in combination with AF on blood urea nitrogen in their study where they used 60 gilts 
(13.9 ± 0.2 kg of BW) for 33 d. These results were also in agreement with Kong et al. (2015). 
There is some evidence that when DON is fed to growing pigs there is no immune 
stimulation in response to the mycotoxin (Bergsjø et al., 1993; Accensi et al., 2006; Weaver et al., 
2013; Kong et al., 2016) but some other studies have shown otherwise (Swamy et al., 2002; 
Tiemann and Dänicke, 2007; Maresca, 2013). However, contrary to Chaytor et al. (2011) and 
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Reddy et al. (2018), during Expt. 2 no effect was seen when a humoral immune response was 
induced with the Leptospira vaccine since the IgG titers were not significantly different across all 
treatments. In a study by Øvernes et al. (1997), 5 different antigens namely human serum albumin 
(HSA), sheep red blood cells (SRBC), paratuberculosis vaccine (MPT), Tetanus Toxoid (TT), and 
Diphtheria Toxoid (DT) were used to try to elicit an immune response in young pigs fed DON-
contaminated diets, HSA showed a primary immune response after 6-wk. TT was also observed 
to elicit a secondary immune response after 9-wk while the other antigens caused no immune 
response. According to Cano et al. (2013), there is evidence from work done in vitro that DON 
may increase susceptibility to diseases in pigs. This increased susceptibility of pigs to diseases was 
suggested to be due to not just DON but also its interaction with other mycotoxins such as ZEA 
and the nutritional effects caused by the DON-induced reduction in feed intake (Pestka et al., 
1987). The lack of immune response also suggests that when DON limits feed intake, the nutrients 
pigs acquire are mostly used for growth and not for use by the immune system (Serviento et al., 
2018). Results from this thesis agree with Kong et al. (2016) who concluded that there was no 
evidence of immune stimulation with DON intake. Overall, it appears that the intake of DON up 
to 5 ppm has little or no effect on animal health. 
 
5.5 DON in urine and serum samples 
 Post-prandial plasma DON levels have been reported to reach a peak within 3-4 h of a 
meal, with DON concentration dropping over time to very low concentrations (Nagl et al., 2014; 
Paulick et al., 2018). Based on this, we measured DON levels in blood plasma in response to a 
meal to determine if this can be used as an indicator of DON exposure. Similar to Dänicke et al. 
(2004), we observed a dose-dependent increase in serum DON, indicating that the more DON is 
consumed, the more DON will be present in the blood. Serum DON levels, therefore, may be used 
as an indicator to predict DON intake. As indicated earlier, there were significant levels of 
detectable DON in the control (CONT) diets used in the finisher N-balance diets.  This DON 
contamination was confirmed by significant levels of DON recovered from serum samples of pigs 
fed the CONT diets. Previous studies by Nagl et al. (2012) and Schwartz-Zimmermann et al. (2014; 
2017) have indicated the main excretion route of DON is urine, hence, we also wanted to determine 
if urine can be used to determine DON exposure.  In the present studies, urine samples collected 
during the N-balance and were analyzed for the presence of DON also showed similar correlating 
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patterns as were observed in the serum. There was generally a positive correlation of DON in urine 
samples to DON in the diet. Again, pigs fed the finisher CONT diets, which on the analysis 
contained significant levels of DON, were also observed to have DON in urine, supporting the 
analytical evidence of potential contamination of the diets. Results from this thesis agree with 
similar studies and further confirms that the main elimination route for DON is through urine ( 
Dänicke et al., 2004; Nagl et al., 2014). Urinary excretion of DON accounts for more than 60% of 
all DON excreted in pigs, whereas fecal excretion accounts for trace amounts (Nagl et al., 2014). 
There was a dose-dependent increase in DON recovered from urine and serum samples (Schwartz-
Zimmermann et al., 2017). Serum and urine can be therefore considered bio-assays to test DON 
exposure since DON excretion is time-dependent and occurs rather rapidly, which leads to 
reduction and recovery in feed intake levels as seen in our results and that of Flannery et al. (2012). 
 
5.6 Summary and implications 
This thesis set out to understand the effects of feeding graded levels of DON-contaminated 
diets to finishing and grower-finisher pigs over a longer-term compared to other studies. Indeed, 
DON negatively affected the ADG, ADFI, and the final BW of pigs, however, while ADG and 
ADFI recovered after 4 weeks during Expt. 1 and 7 - 8 weeks during the Expt. 2  final BW did not 
recover.  There was also no indication of negative effects of DON intake on organ function or 
health of animals.  Overall, our results show that the effects of DON on growth performance is 
mainly due to poor feed intake.  Though results from Expt. 1 and 2 are not statistically comparable, 
it appears that younger pigs were less affected by DON intake, this was evident in the final BW 
weight difference between pigs fed DON5 and pigs fed the CONT diet. While DON intake affected 
growth and feed intake, it did not appear to influence feed efficiency (G:F) and there were no 
effects on carcass characteristics, suggesting that this feed intake effect may be managed or 
mitigated by the alteration of the nutrient content. Another practice that may potentially be applied 
and be beneficial to hog producers could involve altering feed regimes such that DON is introduced 
at specific periods where negative effects of performance will be reduced, such as in the grower 
period. Indeed, a cost and benefit analysis or the use of an economic model may be necessary to 
shed more light on the economic impact of the use of DON-contaminated diets against a more 
traditional feeding system where clean uncontaminated diets are fed to pigs. A modified feeding 
program may include DON in diets fed to pigs but will require increased days to market to maintain 
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the same final BW, as was observed by House et al. (2002).  Analysis of DON content in the test 
diets of the current thesis demonstrates the difficulty in accurately and consistently determining 
the content of mycotoxins in feeds and feedstuffs.  In this study, we demonstrate a strong positive 
correlation between DON intake to DON concentration in biological samples, specifically urine 
and serum. Since DON testing can be challenging, costly, and time-consuming in feeds and 






The studies presented in this thesis provide evidence that DON intake in grower and 
grower-finisher pigs have a negative impact on growth and feed intake, but little effect on nutrient 
utilization, health, and carcass characteristics.  Also, there is evidence that pigs recover from DON 
intake after a period and the negative effects of DON are greater in finisher vs. grower pigs.  The 
information in this thesis will allow for hog producers to develop strategies to minimize the effects 
of DON contamination in the feed while maintaining animal performance and health and 
production profitability.  The results from this thesis will also support grain producers such that 
there may be an auxiliary market for Fusarium damaged kernels or grains.  
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